0001509957 2024-01-01 2024-03-31 0001509957 2024-07-10 0001509957 2024-03-31 0001509957 2023-12-31 0001509957 us-gaap:RelatedPartyMember 2024-03-31 0001509957 us-gaap:RelatedPartyMember 2023-12-31 0001509957 us-gaap:SeriesAPreferredStockMember 2024-03-31 0001509957 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001509957 us-gaap:SeriesCPreferredStockMember 2024-03-31 0001509957 us-gaap:SeriesCPreferredStockMember 2023-12-31 0001509957 us-gaap:SeriesDPreferredStockMember 2024-03-31 0001509957 us-gaap:SeriesDPreferredStockMember 2023-12-31 0001509957 2023-01-01 2023-03-31 0001509957 us-gaap:ProductMember 2024-01-01 2024-03-31 0001509957 us-gaap:ProductMember 2023-01-01 2023-03-31 0001509957 us-gaap:ServiceMember 2024-01-01 2024-03-31 0001509957 us-gaap:ServiceMember 2023-01-01 2023-03-31 0001509957 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001509957 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001509957 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001509957 us-gaap:CommonStockMember 2022-12-31 0001509957 CANB:CommonStockIssuableMember 2022-12-31 0001509957 us-gaap:TreasuryStockCommonMember 2022-12-31 0001509957 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001509957 us-gaap:RetainedEarningsMember 2022-12-31 0001509957 2022-12-31 0001509957 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001509957 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001509957 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001509957 us-gaap:CommonStockMember 2023-12-31 0001509957 CANB:CommonStockIssuableMember 2023-12-31 0001509957 us-gaap:TreasuryStockCommonMember 2023-12-31 0001509957 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001509957 us-gaap:RetainedEarningsMember 2023-12-31 0001509957 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001509957 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001509957 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001509957 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001509957 CANB:CommonStockIssuableMember 2023-01-01 2023-03-31 0001509957 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001509957 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001509957 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001509957 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001509957 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001509957 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001509957 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001509957 CANB:CommonStockIssuableMember 2024-01-01 2024-03-31 0001509957 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001509957 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001509957 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001509957 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001509957 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001509957 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001509957 us-gaap:CommonStockMember 2023-03-31 0001509957 CANB:CommonStockIssuableMember 2023-03-31 0001509957 us-gaap:TreasuryStockCommonMember 2023-03-31 0001509957 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001509957 us-gaap:RetainedEarningsMember 2023-03-31 0001509957 2023-03-31 0001509957 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001509957 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001509957 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001509957 us-gaap:CommonStockMember 2024-03-31 0001509957 CANB:CommonStockIssuableMember 2024-03-31 0001509957 us-gaap:TreasuryStockCommonMember 2024-03-31 0001509957 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001509957 us-gaap:RetainedEarningsMember 2024-03-31 0001509957 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2023-12-31 2023-12-31 0001509957 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2023-12-31 0001509957 us-gaap:FairValueInputsLevel1Member 2024-03-31 0001509957 us-gaap:FairValueInputsLevel2Member 2024-03-31 0001509957 us-gaap:FairValueInputsLevel3Member 2024-03-31 0001509957 us-gaap:FairValueInputsLevel1Member 2023-12-31 0001509957 us-gaap:FairValueInputsLevel2Member 2023-12-31 0001509957 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001509957 us-gaap:MeasurementInputSharePriceMember us-gaap:WarrantMember 2024-03-31 0001509957 us-gaap:MeasurementInputSharePriceMember us-gaap:WarrantMember 2023-12-31 0001509957 us-gaap:MeasurementInputExercisePriceMember us-gaap:WarrantMember 2024-03-31 0001509957 us-gaap:MeasurementInputExercisePriceMember us-gaap:WarrantMember 2023-12-31 0001509957 us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2024-03-31 0001509957 us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2023-12-31 0001509957 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2024-03-31 0001509957 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:WarrantMember 2023-12-31 0001509957 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2024-03-31 0001509957 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2023-12-31 0001509957 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:WarrantMember 2024-03-31 0001509957 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:WarrantMember 2023-12-31 0001509957 CANB:ASOPNoteIMember CANB:ArenaSpecialOpportunitiesPartnersOneLPMember 2020-12-31 0001509957 CANB:ASOPNoteIMember CANB:ArenaSpecialOpportunitiesPartnersOneLPMember 2020-12-01 2020-12-31 0001509957 CANB:ASOPNoteIMember CANB:ArenaSpecialOpportunitiesPartnersOneLPMember 2024-01-01 2024-03-31 0001509957 CANB:ASOFNoteIMember CANB:ArenaSpecialOpportunitiesFundLPMember 2020-12-31 0001509957 CANB:ASOFNoteIMember CANB:ArenaSpecialOpportunitiesFundLPMember 2020-12-01 2020-12-31 0001509957 CANB:ASOFNoteIMember CANB:ArenaSpecialOpportunitiesFundLPMember 2024-01-01 2024-03-31 0001509957 CANB:ASOPNoteIIMember CANB:ArenaSpecialOpportunitiesPartnersOneLPMember 2021-05-31 0001509957 CANB:ASOPNoteIIMember CANB:ArenaSpecialOpportunitiesPartnersOneLPMember 2021-05-01 2021-05-31 0001509957 CANB:ASOPNoteIIMember CANB:ArenaSpecialOpportunitiesPartnersOneLPMember 2024-01-01 2024-03-31 0001509957 CANB:ASOFNoteIIMember CANB:ArenaSpecialOpportunitiesFundLPMember 2021-05-31 0001509957 CANB:ASOFNoteIIMember CANB:ArenaSpecialOpportunitiesFundLPMember 2021-05-01 2021-05-31 0001509957 CANB:ASOFNoteIIMember CANB:ArenaSpecialOpportunitiesFundLPMember 2024-01-01 2024-03-31 0001509957 CANB:HoldersMember CANB:ASOFNoteIIMember 2022-04-14 2022-04-14 0001509957 us-gaap:ConvertibleNotesPayableMember CANB:EmpirePropertiesLLCMember 2022-01-01 0001509957 us-gaap:ConvertibleNotesPayableMember CANB:EmpirePropertiesLLCMember 2022-01-01 2022-01-01 0001509957 us-gaap:ConvertibleNotesPayableMember CANB:EmpirePropertiesLLCMember 2024-01-01 2024-03-31 0001509957 CANB:BLNoteMember CANB:BlueLakePartnersLLCMember 2022-03-31 0001509957 CANB:BLNoteMember CANB:BlueLakePartnersLLCMember 2022-03-01 2022-03-31 0001509957 CANB:BLNoteMember CANB:BlueLakePartnersLLCMember 2023-02-27 2023-02-27 0001509957 srt:MaximumMember CANB:BLNoteMember CANB:BlueLakePartnersLLCMember 2023-02-27 2023-02-27 0001509957 srt:MinimumMember CANB:BLNoteMember CANB:BlueLakePartnersLLCMember 2023-02-27 2023-02-27 0001509957 CANB:BLNoteMember CANB:BlueLakePartnersLLCMember 2024-01-01 2024-03-31 0001509957 CANB:MHNoteMember CANB:MastHillFundLPMember 2022-03-31 0001509957 CANB:MHNoteMember CANB:MastHillFundLPMember 2022-03-01 2022-03-31 0001509957 CANB:MHNoteMember CANB:MastHillFundLPMember 2023-02-27 2023-02-27 0001509957 srt:MaximumMember CANB:MHNoteMember CANB:MastHillFundLPMember 2023-02-27 2023-02-27 0001509957 srt:MinimumMember CANB:MHNoteMember CANB:MastHillFundLPMember 2023-02-27 2023-02-27 0001509957 CANB:MHNoteMember CANB:MastHillFundLPMember 2024-01-01 2024-03-31 0001509957 CANB:FMNoteMember CANB:FourthManLLCMember 2022-04-30 0001509957 CANB:FMNoteMember CANB:FourthManLLCMember 2022-04-01 2022-04-30 0001509957 CANB:FMNoteMember CANB:FourthManLLCMember 2023-02-27 2023-02-27 0001509957 srt:MaximumMember CANB:FMNoteMember CANB:FourthManLLCMember 2023-02-27 2023-02-27 0001509957 srt:MinimumMember CANB:FMNoteMember CANB:FourthManLLCMember 2023-02-27 2023-02-27 0001509957 CANB:FMNoteMember CANB:FourthManLLCMember 2024-01-01 2024-03-31 0001509957 CANB:AlumniNoteMember CANB:AlumniCapitalLPMember 2022-06-30 0001509957 CANB:AlumniNoteMember CANB:AlumniCapitalLPMember 2022-06-01 2022-06-30 0001509957 CANB:AlumniNoteMember CANB:AlumniCapitalLPMember 2024-01-01 2024-03-31 0001509957 CANB:WalleyeOpportunitiesMasterFundNoteMember CANB:WalleyeOpportunitiesMasterFundMember 2022-08-31 0001509957 CANB:WalleyeOpportunitiesMasterFundNoteMember CANB:WalleyeOpportunitiesMasterFundMember 2022-08-01 2022-08-31 0001509957 CANB:WalleyeOpportunitiesMasterFundNoteMember CANB:WalleyeOpportunitiesMasterFundMember 2024-01-01 2024-03-31 0001509957 CANB:TysadcoNoteVIMember CANB:TysadcoPartnersMember 2023-01-31 0001509957 CANB:TysadcoNoteVIMember CANB:TysadcoPartnersMember 2023-01-01 2023-01-31 0001509957 CANB:TysadcoNoteVIMember CANB:TysadcoPartnersMember 2024-01-01 2024-03-31 0001509957 CANB:SecuritiesPurchaseAgreementMember CANB:WOMFMember 2023-03-02 0001509957 CANB:SecuritiesPurchaseAgreementMember CANB:WOMFMember 2023-03-02 2023-03-02 0001509957 srt:MaximumMember us-gaap:InvestorMember CANB:SecuritiesPurchaseAgreementMember 2023-03-02 0001509957 2023-03-02 0001509957 2023-03-02 2023-03-02 0001509957 us-gaap:CommonStockMember CANB:SecuritiesPurchaseAgreementMember CANB:WOMFMember 2023-03-02 0001509957 us-gaap:CommonStockMember CANB:SecuritiesPurchaseAgreementMember CANB:WOMFMember 2023-09-30 0001509957 srt:MinimumMember us-gaap:CommonStockMember CANB:SecuritiesPurchaseAgreementMember CANB:WOMFMember 2023-03-02 0001509957 us-gaap:CommonStockMember CANB:SecuritiesPurchaseAgreementMember CANB:WOMFMember 2023-03-02 2023-03-02 0001509957 us-gaap:InvestorMember 2023-03-02 0001509957 us-gaap:InvestorMember 2023-03-02 2023-03-02 0001509957 srt:MinimumMember us-gaap:InvestorMember 2023-03-02 0001509957 srt:MaximumMember us-gaap:InvestorMember 2023-03-02 0001509957 CANB:PromissoryNoteMember 2023-05-31 0001509957 CANB:PromissoryNoteMember 2023-05-01 2023-05-31 0001509957 CANB:PromissoryNoteMember 2024-01-01 2024-03-31 0001509957 CANB:ForbearanceAgreementMember 2023-05-31 0001509957 CANB:ForbearanceAgreementMember CANB:DuramedMILLCMember 2023-05-01 2023-05-31 0001509957 CANB:HolderMember CANB:WOMFMember 2023-05-31 0001509957 CANB:HolderMember CANB:WOMFMember 2023-05-01 2023-05-31 0001509957 CANB:PromissoryNoteMember CANB:WOMFMember 2023-05-31 0001509957 CANB:WOMFMember 2023-05-31 0001509957 CANB:HolderMember CANB:PromissoryNoteMember CANB:WOMFMember 2023-05-01 2023-05-31 0001509957 CANB:HolderMember CANB:PromissoryNoteMember CANB:WOMFMember 2023-05-31 0001509957 CANB:EquipmentAcquisitionAgreementMember 2021-08-12 0001509957 CANB:EquipmentAcquisitionAgreementMember 2021-08-11 2021-08-12 0001509957 CANB:EquipmentAcquisitionAgreementMember 2024-03-31 0001509957 us-gaap:InvestorMember CANB:SecuritiesPurchaseAgreementMember 2023-10-27 0001509957 srt:MaximumMember CANB:InitialNoteMember CANB:StockPurchaseAgreementMember 2023-10-27 0001509957 us-gaap:InvestorMember CANB:SecuritiesPurchaseAgreementMember 2024-03-31 0001509957 CANB:InitialNoteMember us-gaap:CommonStockMember CANB:StockPurchaseAgreementMember 2023-10-27 2023-10-27 0001509957 us-gaap:InvestorMember CANB:NotesMember 2023-10-27 0001509957 CANB:StockPurchaseAgreementMember 2023-10-27 2023-10-27 0001509957 CANB:StockPurchaseAgreementMember 2023-10-27 0001509957 CANB:InitialNoteMember CANB:StockPurchaseAgreementMember 2023-10-27 0001509957 CANB:InitialNoteMember CANB:StockPurchaseAgreementMember 2023-10-27 2023-10-27 0001509957 2023-10-27 0001509957 CANB:ConsolidatedNoteMember 2023-10-27 2023-10-27 0001509957 CANB:HolderMember CANB:WOMFMember 2023-09-30 0001509957 CANB:PromissoryNoteMember 2023-09-30 2023-09-30 0001509957 CANB:HolderMember CANB:WOMFMember 2023-12-31 0001509957 CANB:PromissoryNoteMember 2023-01-01 2023-12-31 0001509957 CANB:PromissoryNoteMember 2023-12-31 0001509957 CANB:HolderMember CANB:ClearThinkMember 2024-02-29 0001509957 CANB:PromissoryNoteMember 2024-02-29 2024-02-29 0001509957 CANB:PromissoryNoteMember 2024-02-29 0001509957 2022-01-01 2022-12-31 0001509957 srt:MaximumMember 2022-01-01 2022-12-31 0001509957 srt:MinimumMember 2022-01-01 2022-12-31 0001509957 CANB:DueWithinSixMonthsMember CANB:LenderMember CANB:UnsecuredPromissoryNoteAgreementMember 2022-02-11 0001509957 CANB:DueWithinSixMonthsMember CANB:LenderMember CANB:UnsecuredPromissoryNoteAgreementMember 2022-02-09 2022-02-11 0001509957 CANB:DueWithinSixMonthsMember CANB:LenderMember CANB:UnsecuredPromissoryNoteAgreementMember 2024-03-31 0001509957 CANB:DueOnOctoberThirtyOneTwoThousandTwentyTwoMember CANB:LenderMember CANB:UnsecuredPromissoryNoteAgreementMember 2022-10-14 0001509957 CANB:DueOnOctoberThirtyOneTwoThousandTwentyTwoMember CANB:LenderMember CANB:UnsecuredPromissoryNoteAgreementMember 2024-03-31 0001509957 CANB:DueOnDecemberSeventeenTwoThousandTwentyTwoMember CANB:LenderMember CANB:UnsecuredPromissoryNoteAgreementMember 2022-11-17 0001509957 CANB:DueOnDecemberSeventeenTwoThousandTwentyTwoMember CANB:LenderMember CANB:UnsecuredPromissoryNoteAgreementMember 2024-03-31 0001509957 CANB:VariousLendersMember 2023-03-02 0001509957 CANB:VariousLendersMember 2023-03-02 2023-03-02 0001509957 CANB:PatFerroMember 2024-03-31 0001509957 us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-03-31 0001509957 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001509957 us-gaap:SeriesDPreferredStockMember 2024-01-01 2024-03-31 0001509957 us-gaap:SeriesDPreferredStockMember 2021-03-27 0001509957 us-gaap:SeriesDPreferredStockMember 2021-02-07 2021-02-08 0001509957 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001509957 srt:MinimumMember 2024-03-31 0001509957 srt:MaximumMember 2024-03-31 0001509957 2023-01-01 2023-12-31 0001509957 us-gaap:SubsequentEventMember CANB:PurchaseAgreementMember 2024-06-01 2024-06-30 iso4217:USD shares iso4217:USD shares pure utr:lb CANB:Segment true Q1 --12-31 0001509957 10-Q/A true 2024-03-31 2024 false 000-55753 Can B Corp. FL 20-3624118 960 South Broadway Suite 120 Hicksville NY 11801 516 595-9544 Yes Yes Non-accelerated Filer true false false 61909230 This Amendment No. 1 to Quarterly Report on Form 10-Q/A (this “Amended Report”) is filed with the Securities and Exchange Commission to amend the Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Original 10-Q”) of Can B Corp. (the “Company”) to incorporate the review by its new independent registered public accounting firm as the Original 10-Q was filed without auditor review due to the permanent suspension of BF Borgers by the SEC 26582 34006 2818395 3599026 3723344 593375 1619542 10137 4137 4229120 5381029 235418 235418 95144 649079 4106283 192087 295151 16555 13139 1093139 4745135 5322259 10126164 2264972 1997643 366243 357243 7611233 8569489 1766 1766 150679 254391 10394893 11180532 10394893 11180532 5000000 5000000 0 0 20 20 5 5 5 5 5320000 5320000 0.001 0.001 2000 2000 1100 1100 1100 1100 2900039 2900039 0.001 0.001 4000 4000 4000 4000 4000 4000 4 4 0 0 1500000000 1500000000 44798583 44798583 32753196 32753196 84242372 83263105 0 0 36248 36248 119586 119586 572678 572678 11559910 10396274 -108641867 -102480698 -5072634 -1054368 5322259 10126164 808748 369096 130557 369096 939305 1193161 524577 -824065 414728 1688058 1849630 3142769 4830827 1849630 -5654892 -1434902 -79418 506182 333967 -95 -39990 -506277 -294539 -6161169 -1729441 9596 -6161169 -1739038 -0.16 -0.16 -0.36 -0.36 37349748 37349748 4896524 4896524 5 5320000 1100 2900039 4000 4 4422584 79614986 119586 36248 -572678 8006822 -92690834 2697925 577850 521557 521557 937787 937787 360000 36005 36005 -1739038 -1739038 5 5320000 1100 2900039 4000 4 5360434 80172548 119586 36248 -572678 8944609 -94429872 2454236 5 5320000 1100 2900039 4000 4 32753196 83263105 119586 36248 -572678 10396274 -102480698 -1054368 5 5320000 1100 2900039 4000 4 32753196 83263105 119586 36248 -572678 10396274 -102480698 -1054368 11866995 964764 964764 178392 14503 14503 1163636 1163636 -6161169 -6161169 5 5320000 1100 2900039 4000 4 44798583 84242372 119586 36248 -572678 11559910 -108641867 -5072634 5 5320000 1100 2900039 4000 4 44798583 84242372 119586 36248 -572678 11559910 -108641867 -5072634 -6161169 -1739038 1163636 314435 346887 3000 239782 218146 91728 -3142769 86365 -79418 14503 36005 521557 -124318 392669 -1026167 8122 6000 7448 648 -142 267329 108316 144 216850 -906133 15000 70000 -85000 100000 1730000 333274 507813 143000 9000 35000 -224274 1114187 -7424 123054 34006 73194 26582 196248 964764 273529 937787 <p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zWIL8VMQzkMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_823_z3q11CRUh679">Organization and Description of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Can B̅ Corp. was originally incorporated as WrapMail, Inc. (“WRAP”) in Florida on October 11, 2005. On May 15, 2017, WRAP changed its name to Canbiola, Inc. On January 16, 2020 Canbiola, Inc. changed its name to Can B̅ Corp. (the “Company”, “we”, “us”, “our”, “CANB”, “Can B̅” or “Registrant”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company acquired 100% of the membership interests in Pure Health Products, LLC, a New York limited liability company (“PHP” or “Pure Health Products”) effective December 28, 2018. The Company runs its manufacturing operations through PHP and holds and sells several of its brands through PHP as well. The Company’s durable equipment products, such as Sam® units are marketed and sold through its wholly-owned subsidiaries, Duramed Inc. (incorporated on November 29, 2018) and Duramed MI LLC (fka DuramedNJ, LLC) (incorporated on May 29, 2019) (collectively, “Duramed”). Duramed began operating on or about February 1, 2019. Most of the Company’s consumer products include hemp derived cannabidiol (“CBD”) are available online. Additional hemp derived isolate is available for wholesale to third-parties looking to incorporate such compounds into their products through the Company’s wholly owned subsidiary CO Botanicals LLC (incorporated in August 2021). In February of 2024, Can B̅ Corp’s 67% owned subsidiary, Nascent Pharma, LLC, acquired certain Patents using liquid formulations containing cannabinoids which are used in such products as vape cartridges, edibles, pills, gummies, tinctures, oils, concentrates and more.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Today, <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company is in the business of promoting health and wellness through its development, manufacture and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devises. Can B̅’s products include oils, creams, moisturizers, isolate, gel caps, spa products, and concentrates. Can B̅ develops its own line of proprietary products as well seeks synergistic value through acquisitions in the hemp industry. Can B̅ aims to be a provider of the highest quality hemp derived products on the market through sourcing the best raw material and offering a variety of products we believe will improve people’s lives in a variety of areas. Can B̅ also plans to commercialize and enforce the patents recently acquired by Nascent Pharma, LLC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80B_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z0fOIueewQt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – <span id="xdx_821_zw4i5hqDKPj8">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements have been prepared on a “going concern” basis, which contemplates the realization of assets and liquidation of liabilities in a normal course of business. As of March 31, 2024, the Company had cash and cash equivalents of $<span id="xdx_902_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20240331_zBiTZGE6uxE3">26,582</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and negative working capital of $<span id="xdx_901_ecustom--WorkingCapital_iI_c20240331_zTBccqgJTB4i" title="Working capital">6,165,773</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. For the three months ended March 31, 2024, the Company incurred losses of $<span id="xdx_909_eus-gaap--NetIncomeLoss_iN_di_c20240101__20240331_z2XqwPZK5U1g">6,161,169</span> which made the total accumulated deficit $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20240331_zy2X76LO8uca" title="Accumulated deficit">108,641,867</span> through March 31, 2024. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These factors raise substantial doubt as to the Company’s ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is currently funding its operations on a month-to-month basis through third party loans. In March 2024, certain equipment used in the operation of the Company’s hemp division was sold in an auction conducted under Article 9 of the Uniform Commercial Code. The auction resulted in proceeds of approximately $<span id="xdx_901_eus-gaap--RepaymentsOfRelatedPartyDebt_c20240101__20240331_z7tbEVpn60W5" title="Related party debt">300,000</span> which were applied to the Company’s obligations under convertible notes held by Arena Special Opportunities Partners I, L.P. and its affiliates. In June 2024, the Company’s Board of Directors concluded that as a result of the impact of the auction on the hemp division, it is no longer feasible to continue the Company’s hemp operations. As a result, the Company will no longer pursue the development, manufacture or sale of hemp derived products.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, revenues from the Company’s hemp division supported, in part, its durable medical equipment business conducted through Duramed. Due to the elimination of support from the hemp division, Duramed is operating with reduced staff which has adversely impacted revenues.</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s ability to continue its operations is dependent on the execution of management’s plans, which include protecting and commercializing the cannabis patents recently acquired by Nascent Pharma, LLC, raising litigation funding to support Nascent Pharma’s patent protection efforts, continuing to collect Duramed receivables, reestablishing the Company’s production of the Longevity Brand Superfood drink mix for Brooke Burke Body, Inc., restructuring outstanding indebtedness and raising of capital through the debt and/or equity markets. The consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. If the Company is not to continue as a going concern, it would likely not be able to realize its assets at values comparable to the carrying value or the fair value estimates reflected in the balances set out in its financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">There can be no assurances that the Company will be successful in generating additional cash from equity or debt financings or other sources to be used for operations. Should the Company not be successful in obtaining the necessary financing to fund its operations, it would need to curtail certain or all operational activities and/or contemplate the sale of its assets, if necessary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 26582 6165773 -6161169 -108641867 300000 <p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zgwSullS5icl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3 – <span id="xdx_820_zDcLH2eMKZEk">Basis of Presentation and Summary of Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zXVBSbdgX8M3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zKL63JrxC049">Basis of Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information, and with the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, these interim consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of the management of the Company, as defined below, these unaudited consolidated financial statements include all adjustments necessary to present fairly the information set forth therein. Results for interim periods are not necessarily indicative of results to be expected for a full year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated balance sheet information as of December 31, 2023 was derived from the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (“2023 Form 10-K”). The interim consolidated financial statements contained herein should be read in conjunction with the 2023 Form 10-K.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zceQgcpmJI57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zwtApd2VW4o">Principles of Consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements contained herein include the accounts of Can B Corp. and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--UseOfEstimates_zPIO5yYnw3if" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zZpOAzVWqpni">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses in those financial statements. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, inventory, intangible assets and other long-lived assets, income taxes and deferred taxes. Descriptions of these policies are discussed in the Company’s 2023 Form 10-K. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and adjusts when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--SignificantAccountingPoliciesPolicyTextBlock_zLmdln0y4iE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zBs1aZ9Bzqxh">Significant Accounting Policies</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s significant accounting policies are described in “Note 3: Summary of Significant Accounting Policies” of our 2023 Form 10-K.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z6vVIF7u7EWl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z8sYX9mTX7Ch">Segment reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the Company reports operating results and financial data in one operating and reportable segment. The Chief Executive Officer, who is the chief operating decision maker, manages the Company as a single profit center in order to promote collaboration, provide comprehensive service offerings across the entire customer base, and provide incentives to employees based on the success of the organization as a whole. Although certain information regarding selected products or services is discussed for purposes of promoting an understanding of the Company’s business, the chief operating decision maker manages the Company and allocates resources at the consolidated level.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p id="xdx_85E_zyvoZmm2i7O2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Reclassifications</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Certain amounts in the prior year consolidated financial statements have been reclassified to conform to the current year presentation. These reclassification adjustments had no effect on the Company</span><span style="font-family: Segoe UI, Helvetica, Sans-Serif">’</span><span style="font-family: Times New Roman, Times, Serif">s previously reported net loss. December 2023 revenues and accounts payable were misstated and a correction of $<span id="xdx_90F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20231231__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_zA1LPY6PDYUg" title="Revenue"><span id="xdx_90E_eus-gaap--AccountsPayableCurrent_iI_c20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_z6y09qU2E8Ia" title="Accounts payable">52,400</span></span> was made related to a transaction reversal with a vendor.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zXVBSbdgX8M3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zKL63JrxC049">Basis of Financial Statement Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information, and with the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, these interim consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of the management of the Company, as defined below, these unaudited consolidated financial statements include all adjustments necessary to present fairly the information set forth therein. Results for interim periods are not necessarily indicative of results to be expected for a full year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated balance sheet information as of December 31, 2023 was derived from the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (“2023 Form 10-K”). The interim consolidated financial statements contained herein should be read in conjunction with the 2023 Form 10-K.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zceQgcpmJI57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zwtApd2VW4o">Principles of Consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements contained herein include the accounts of Can B Corp. and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--UseOfEstimates_zPIO5yYnw3if" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zZpOAzVWqpni">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses in those financial statements. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, inventory, intangible assets and other long-lived assets, income taxes and deferred taxes. Descriptions of these policies are discussed in the Company’s 2023 Form 10-K. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and adjusts when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--SignificantAccountingPoliciesPolicyTextBlock_zLmdln0y4iE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zBs1aZ9Bzqxh">Significant Accounting Policies</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s significant accounting policies are described in “Note 3: Summary of Significant Accounting Policies” of our 2023 Form 10-K.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notes to Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--SegmentReportingPolicyPolicyTextBlock_z6vVIF7u7EWl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_z8sYX9mTX7Ch">Segment reporting</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2024, the Company reports operating results and financial data in one operating and reportable segment. The Chief Executive Officer, who is the chief operating decision maker, manages the Company as a single profit center in order to promote collaboration, provide comprehensive service offerings across the entire customer base, and provide incentives to employees based on the success of the organization as a whole. Although certain information regarding selected products or services is discussed for purposes of promoting an understanding of the Company’s business, the chief operating decision maker manages the Company and allocates resources at the consolidated level.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> 52400 52400 <p id="xdx_807_eus-gaap--FairValueMeasurementInputsDisclosureTextBlock_zOEt8DAqJhI2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4 – <span id="xdx_828_zhHsuxoQubv2">Fair Value Measurements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zt1iXcZar7b2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value and fair value of the Company’s financial instruments are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_z6THLRJ9DBT9" style="display: none">Schedule of Carrying Value and Fair Value</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_494_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z84DIy1w4PRk" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 1</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49B_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzIijo6fAX69" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 2</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_492_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpGUWum8Hwrc" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 3</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49B_20240331_zMxRfZuXXSrd" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom">March 31, 2024</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 1</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 2</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 3</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LiabilitiesFairValueDisclosure_iI_zMBrNCBWDV98" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left">Warrant liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0656">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0657">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,766</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,766</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_495_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0NKjDS3MkJ5" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 1</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_495_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zYcqZVyTzWMd" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 2</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_493_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ztWHfGxZdN16" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 3</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_498_20231231_zsa97aLLj7pd" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom">As of December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="14"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 1</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 2</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 3</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--LiabilitiesFairValueDisclosure_iI_zCTAZb1FXfUb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Warrant liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0661">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0662">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,766</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,766</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zNrEgXm0E11b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_zzZZLSWbj2ue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the warrants outstanding was estimated using the Black-Scholes model. The application of the Black-Scholes model requires the use of a number of inputs and significant assumptions including volatility. The following reflects the inputs and assumptions used:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zmmjNY56H2Ah" style="display: none">Schedule of Fair Value Assumptions</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">As of</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOr9BSrD3noh"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zaBuYiI1UTP3"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_za2mRBCmoFyj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Stock price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.03</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.07</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zbgQvhREdyTf" style="vertical-align: bottom; background-color: White"> <td>Exercise price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z81bFIPPGyIl" title="Remaining term (in years)">3.25</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zz4lGkqqStce" title="Remaining term (in years)">3.50</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zJg5P0ncNaek" style="vertical-align: bottom; background-color: White"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">165.2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">171.8</td><td style="text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zFFhSJgIX23g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.9</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.84</td><td style="text-align: left">%</td></tr> <tr id="xdx_40E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zB4aMc3ek4a4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0684">—</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0685">—</span></td><td style="text-align: left">%</td></tr> <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zU38qCeelxKd" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif">Warrant measurement input</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0687">—</span></td><td style="text-align: left"></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0688">—</span></td><td style="text-align: left"></td></tr> </table> <p id="xdx_8AF_zMLiwJ8KqGvf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zErCRT6od3eb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrant liabilities will be remeasured at each reporting period with changes in fair value recorded in other income (expense), net on the consolidated statements of operations. The change in fair value of the warrant liabilities was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zWaT1drxQal4" style="display: none">Schedule of Change in Fair Value of the Warrant Liabilities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Warrant liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_4B2_zXxCchUoG3p5" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_43B_c20230101__20230331_eus-gaap--LiabilitiesFairValueDisclosure_iS_zRrTPueYdImk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; width: 84%">Estimated fair value at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">203,043</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--IssuanceOfWarrantLiabilities_zcU79Xs8mrP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Issuance of warrant liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0694">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FairValueAdjustmentOfWarrants_zz9iguFpqkBc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(79,418</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_43F_c20230101__20230331_eus-gaap--LiabilitiesFairValueDisclosure_iE_zIK4USbZsyT6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Estimated fair value at March 31, 2023</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">123,625</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_430_c20240101__20240331_eus-gaap--LiabilitiesFairValueDisclosure_iS_zS2VuVza2hnb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Estimated fair value at December 31, 2023</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,766</td><td style="text-align: left"> </td></tr> <tr id="xdx_43B_c20240101__20240331_eus-gaap--LiabilitiesFairValueDisclosure_iS_zqdJiVEXQma8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Estimated fair value at beginning balance</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,766</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FairValueAdjustmentOfWarrants_zEx2coAOs5ge" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0704">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_43E_c20240101__20240331_eus-gaap--LiabilitiesFairValueDisclosure_iE_z3awEO1DG0s9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Estimated fair value at March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_43F_c20240101__20240331_eus-gaap--LiabilitiesFairValueDisclosure_iE_zl3HiNiuRB55" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Estimated fair value at ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zZb0sfpY1BDl" style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zt1iXcZar7b2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value and fair value of the Company’s financial instruments are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_z6THLRJ9DBT9" style="display: none">Schedule of Carrying Value and Fair Value</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_494_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z84DIy1w4PRk" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 1</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49B_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zzIijo6fAX69" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 2</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_492_20240331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zpGUWum8Hwrc" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 3</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49B_20240331_zMxRfZuXXSrd" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom">March 31, 2024</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 1</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 2</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 3</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LiabilitiesFairValueDisclosure_iI_zMBrNCBWDV98" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left">Warrant liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0656">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0657">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,766</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,766</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_495_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z0NKjDS3MkJ5" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 1</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_495_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zYcqZVyTzWMd" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 2</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_493_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ztWHfGxZdN16" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 3</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" id="xdx_498_20231231_zsa97aLLj7pd" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom">As of December 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="14"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 1</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 2</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level 3</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_408_eus-gaap--LiabilitiesFairValueDisclosure_iI_zCTAZb1FXfUb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Warrant liabilities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0661">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0662">—</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,766</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,766</td><td style="width: 1%; text-align: left"> </td></tr> </table> 1766 1766 1766 1766 <p id="xdx_890_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_zzZZLSWbj2ue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the warrants outstanding was estimated using the Black-Scholes model. The application of the Black-Scholes model requires the use of a number of inputs and significant assumptions including volatility. The following reflects the inputs and assumptions used:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B4_zmmjNY56H2Ah" style="display: none">Schedule of Fair Value Assumptions</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">As of</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zOr9BSrD3noh"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zaBuYiI1UTP3"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"> </td></tr> <tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_za2mRBCmoFyj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Stock price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.03</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.07</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zbgQvhREdyTf" style="vertical-align: bottom; background-color: White"> <td>Exercise price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6.40</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining term (in years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z81bFIPPGyIl" title="Remaining term (in years)">3.25</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zz4lGkqqStce" title="Remaining term (in years)">3.50</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zJg5P0ncNaek" style="vertical-align: bottom; background-color: White"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">165.2</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">171.8</td><td style="text-align: left">%</td></tr> <tr id="xdx_401_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zFFhSJgIX23g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.9</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.84</td><td style="text-align: left">%</td></tr> <tr id="xdx_40E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zB4aMc3ek4a4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0684">—</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0685">—</span></td><td style="text-align: left">%</td></tr> <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zU38qCeelxKd" style="display: none; vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif">Warrant measurement input</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0687">—</span></td><td style="text-align: left"></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0688">—</span></td><td style="text-align: left"></td></tr> </table> 0.03 0.07 6.40 6.40 P3Y3M P3Y6M 165.2 171.8 3.9 3.84 <p id="xdx_89B_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zErCRT6od3eb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The warrant liabilities will be remeasured at each reporting period with changes in fair value recorded in other income (expense), net on the consolidated statements of operations. The change in fair value of the warrant liabilities was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zWaT1drxQal4" style="display: none">Schedule of Change in Fair Value of the Warrant Liabilities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Warrant liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_4B2_zXxCchUoG3p5" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_43B_c20230101__20230331_eus-gaap--LiabilitiesFairValueDisclosure_iS_zRrTPueYdImk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; width: 84%">Estimated fair value at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">203,043</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--IssuanceOfWarrantLiabilities_zcU79Xs8mrP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Issuance of warrant liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0694">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FairValueAdjustmentOfWarrants_zz9iguFpqkBc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(79,418</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_43F_c20230101__20230331_eus-gaap--LiabilitiesFairValueDisclosure_iE_zIK4USbZsyT6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Estimated fair value at March 31, 2023</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">123,625</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_430_c20240101__20240331_eus-gaap--LiabilitiesFairValueDisclosure_iS_zS2VuVza2hnb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Estimated fair value at December 31, 2023</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,766</td><td style="text-align: left"> </td></tr> <tr id="xdx_43B_c20240101__20240331_eus-gaap--LiabilitiesFairValueDisclosure_iS_zqdJiVEXQma8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Estimated fair value at beginning balance</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,766</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FairValueAdjustmentOfWarrants_zEx2coAOs5ge" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0704">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_43E_c20240101__20240331_eus-gaap--LiabilitiesFairValueDisclosure_iE_z3awEO1DG0s9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Estimated fair value at March 31, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_43F_c20240101__20240331_eus-gaap--LiabilitiesFairValueDisclosure_iE_zl3HiNiuRB55" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Estimated fair value at ending balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 203043 -79418 123625 1766 1766 1766 1766 <p id="xdx_80A_eus-gaap--InventoryDisclosureTextBlock_zDWkydRZNM83" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 – <span id="xdx_827_zp4jswts8jO3">Inventories</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zkM5HO15wLf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zyWom49EqvD9" style="display: none">Schedule of Inventories</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_497_20240331_zPsbPxAiYoH1" style="vertical-align: bottom; font-weight: bold; text-align: center">March 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49A_20231231_z1y2STdPUauj" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40C_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzR5m_zuRNKVLl5wCb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">221,030</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,196,112</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzR5m_zhtSfUk6YvAd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">372,345</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">423,430</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryNet_iTI_pp0p0_mtINzR5m_z6cIjt9FuAM7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">593,375</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,619,542</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zaV27w4OQRU" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zkM5HO15wLf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zyWom49EqvD9" style="display: none">Schedule of Inventories</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_497_20240331_zPsbPxAiYoH1" style="vertical-align: bottom; font-weight: bold; text-align: center">March 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_49A_20231231_z1y2STdPUauj" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40C_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzR5m_zuRNKVLl5wCb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">221,030</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,196,112</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maINzR5m_zhtSfUk6YvAd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">372,345</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">423,430</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryNet_iTI_pp0p0_mtINzR5m_z6cIjt9FuAM7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">593,375</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,619,542</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 221030 1196112 372345 423430 593375 1619542 <p id="xdx_808_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zvHkhrVoq1Ld" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6 –<span id="xdx_82C_zKX1OyrwQr94"> Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_znnHwbXWJucl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zcpKDHGanQvj" style="display: none">Schedule of Property and Equipment</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_492_20240331_z7SYIasbKM52" style="vertical-align: bottom; font-weight: bold; text-align: center">March 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_499_20231231_zJcyxsbPNWYd" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40F_eus-gaap--FurnitureAndFixturesGross_iI_pp0p0_maPPAEGzfn2_zp4ugWkY46Fk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Furniture and fixtures</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,706</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21,724</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FixturesAndEquipmentGross_iI_pp0p0_maPPAEGzfn2_zRnbWP7SVKK2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0730">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,378</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--MachineryAndEquipmentGross_iI_pp0p0_maPPAEGzfn2_zGIDn86couv4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Manufacturing equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">468,264</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,828,083</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--MedicalEquipment_iI_pp0p0_maPPAEGzfn2_zlySFkk1GtY2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Medical equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">776,396</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">776,396</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LeaseholdImprovementsGross_iI_pp0p0_maPPAEGzfn2_z18e69rjSYE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Leasehold improvements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,902</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,902</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iTI_pp0p0_mtPPAEGzfn2_maPPAENzsDP_z1LcJLBmJvIc" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,274,268</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,665,483</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzsDP_z4ztraMLL271" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(625,189</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,559,200</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzsDP_zhFdN1QvNpWj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">649,079</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,106,283</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zxyRBn9Sczvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense related to property and equipment was $<span id="xdx_901_eus-gaap--DepreciationAndAmortization_pp0p0_c20240101__20240331_zVPWObjR8bA1" title="Depreciation">314,435</span> and $<span id="xdx_901_eus-gaap--DepreciationAndAmortization_pp0p0_c20230101__20230331_zvdA9on5W953" title="Depreciation">346,887</span> for the three months ended March 31, 2024 and 2023, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the sale of certain assets related to the Arena Notes, the Company recorded as loss on sales of property and equipment of $<span id="xdx_902_eus-gaap--GainLossOnSaleOfPropertyPlantEquipment_iN_di_c20240101__20240331_zMm4E8DWJ2Ec" title="Loss on sale of property and equipment">3,142,769</span> during the three months ended March 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_znnHwbXWJucl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B5_zcpKDHGanQvj" style="display: none">Schedule of Property and Equipment</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_492_20240331_z7SYIasbKM52" style="vertical-align: bottom; font-weight: bold; text-align: center">March 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_499_20231231_zJcyxsbPNWYd" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_40F_eus-gaap--FurnitureAndFixturesGross_iI_pp0p0_maPPAEGzfn2_zp4ugWkY46Fk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Furniture and fixtures</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,706</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">21,724</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FixturesAndEquipmentGross_iI_pp0p0_maPPAEGzfn2_zRnbWP7SVKK2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Office equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0730">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,378</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--MachineryAndEquipmentGross_iI_pp0p0_maPPAEGzfn2_zGIDn86couv4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Manufacturing equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">468,264</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,828,083</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--MedicalEquipment_iI_pp0p0_maPPAEGzfn2_zlySFkk1GtY2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Medical equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">776,396</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">776,396</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LeaseholdImprovementsGross_iI_pp0p0_maPPAEGzfn2_z18e69rjSYE5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Leasehold improvements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,902</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,902</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iTI_pp0p0_mtPPAEGzfn2_maPPAENzsDP_z1LcJLBmJvIc" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,274,268</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,665,483</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzsDP_z4ztraMLL271" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(625,189</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,559,200</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzsDP_zhFdN1QvNpWj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">649,079</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,106,283</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2706 21724 12378 468264 6828083 776396 776396 26902 26902 1274268 7665483 625189 3559200 649079 4106283 314435 346887 -3142769 <p id="xdx_805_eus-gaap--IntangibleAssetsDisclosureTextBlock_zX1bfOSi6gTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7 – <span id="xdx_823_zVWRFlRNKsO2">Intangible Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_z9usJDitvyJd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_z0IQNlFkX2Ui" style="display: none">Schedule of Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_499_20240331_z3B6YGs1fwal" style="vertical-align: bottom; font-weight: bold; text-align: center">March 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_498_20231231_z6EYY54E27D4" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_401_ecustom--FiniteLivedTechnologyIpAndPatents_iI_pp0p0_maFLIAGzTbJ_z2da34Ek0Jmb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Technology, IP and patents</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0761">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">119,998</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsGross_iTI_pp0p0_mtFLIAGzTbJ_maFLIANzXUa_zmqw8dyWWn26" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">119,998</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzXUa_zRe7CSHjWiw2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">      <span style="-sec-ix-hidden: xdx2ixbrl0767">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24,854</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzXUa_zQbXoshIvAHe" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">95,144</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zsn520kKwoxi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense was $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20230101__20230331_zMM1oI5dSM54" title="Amortization expense">3,000</span> for the three months ended March 31, 2023. During the three months ended March 31, 2024, the Company recorded impairment expense of $<span id="xdx_902_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_c20240101__20240331_zOaGG0Y9POfg" title="Impairment of intangible assets">91,728</span> related to its intangible assets which is included in selling, general and administrative in the condensed consolidated statements of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_z9usJDitvyJd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_z0IQNlFkX2Ui" style="display: none">Schedule of Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_499_20240331_z3B6YGs1fwal" style="vertical-align: bottom; font-weight: bold; text-align: center">March 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td> <td colspan="2" id="xdx_498_20231231_z6EYY54E27D4" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"> </td></tr> <tr id="xdx_401_ecustom--FiniteLivedTechnologyIpAndPatents_iI_pp0p0_maFLIAGzTbJ_z2da34Ek0Jmb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt">Technology, IP and patents</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0761">-</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right">119,998</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsGross_iTI_pp0p0_mtFLIAGzTbJ_maFLIANzXUa_zmqw8dyWWn26" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0764">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">119,998</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_pp0p0_di_msFLIANzXUa_zRe7CSHjWiw2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">      <span style="-sec-ix-hidden: xdx2ixbrl0767">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(24,854</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzXUa_zQbXoshIvAHe" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0770">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">95,144</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 119998 119998 24854 95144 3000 91728 <p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zRC9ar2Xq2fi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8 – <span id="xdx_82D_zgzDGzoMQs8k">Notes and Loans Payable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible Promissory Notes</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2020, the Company entered into a convertible promissory note (“ASOP Note I”) with Arena Special Opportunities Partners I, LP (“ASOP”). The original principal amount of the note was $<span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zENfMBJ42cr1" title="Total notes and loans payable">2,675,239</span> and the proceeds were utilized for working capital purposes. The note matured on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_pp0p0_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_z6D8PUZQXzNa" title="Debt instrument, maturity date">January 31, 2022</span> and all principal, accrued and unpaid interest was due at maturity at a rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201231__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zqONFrchc8s7" title="Debt instrument, interest rate">12</span>% per annum. The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered a derivative and therefore has been recorded in liabilities as part of the convertible promissory note and not bifurcated. In addition, the ASOP convertible promissory note was issued with <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zLn79Boz6Ag7" title="Number of shaes issued">228,419</span> common stock warrants. The common stock purchase warrants entitle the holder to purchase an aggregate of up to <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zOIrZmZupKie" title="Number of shaes issued">228,419</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_908_eus-gaap--SharePrice_iI_pp2d_c20201231__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zf3mtMebCRgj" title="Exercise price">6.75</span> per share. The common stock purchase warrants issued to ASOP are considered derivatives, but satisfied the criteria for classification as equity instruments, and were bifurcated from the host contract - convertible promissory note and recorded in equity at their relative fair values with a corresponding debt discount recorded to ASOP Note I. The principal balance outstanding at March 31, 2024 was $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zgrcOd9yXCX5" title="Debt instrument principal reduction payment">2,400,997</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2020, the Company entered into a convertible promissory note (“ASOF Note I”) with Arena Special Opportunities Fund, LP (“ASOF”). The principal balance of the note is $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zIsUgGMLi2w1" title="Principal balance">102,539</span> and was utilized for working capital purposes. The note matured on <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zWWMq3tUd6J4" title="Debt instrument, maturity date">January 31, 2022</span> and all principal, accrued and unpaid interest was due at maturity at a rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201231__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zjxeILC0qI2j" title="Debt instrument, interest rate">12</span>% per annum. The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered a derivative and therefore has been recorded in liabilities as part of the convertible promissory note and not bifurcated. In addition, the ASOF convertible promissory note was issued with <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_z1BhltTsm9o3" title="Number of shares issued">8,755</span> common stock warrants. The common stock purchase warrants entitle the holder to purchase an aggregate of up to <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20201231__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zWVsUrp1iBVi" title="Warrants to purchase common stock">8,755</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zj7UEP9Cahe8" title="Warrants exercise price">6.75</span> per share. The common stock purchase warrants issued to ASOF are considered derivatives, but satisfied the criteria for classification as equity instruments, and were bifurcated from the host contract - convertible promissory note and recorded in equity at their relative fair values with a corresponding debt discount recorded to ASOF Note I. The principal balance outstanding at March 31, 2024 was $<span id="xdx_90B_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zJb9PbrQcxik" title="Debt instrument principal reduction payment">87,773</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the Company entered into a convertible promissory note (“ASOP Note II”) with Arena Special Opportunities Partners I, LP. The principal balance of the note is $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20210531__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zabwuBzw7Fxh" title="Total notes and loans payable">1,193,135</span> and it is to be utilized for working capital purposes. The note matures on <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20210501__20210531__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zHHlpSgSpKal" title="Debt instrument, maturity date">January 31, 2022</span> and all principal, accrued and unpaid interest is due at maturity at a rate of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210531__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_z6fvzGKceEIk" title="Debt instrument, interest rate">12</span>% per annum. The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered a derivative and therefore has been recorded in liabilities as part of the convertible promissory note and not bifurcated. In addition, the ASOP convertible promissory note was issued with <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210501__20210531__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zMgEMQnFUQVk" title="Number of shares issued">101,978</span> common stock warrants. The common stock purchase warrants entitle the holder to purchase an aggregate of up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210531__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zJpiJHpD5BN" title="Warrants to purchase common stock">101,978</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210531__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zYSntKgKk4ad" title="Warrants exercise price">6.75</span> per share. The common stock purchase warrants issued to ASOP are considered derivatives, but satisfied the criteria for classification as equity instruments, and were bifurcated from the host contract - convertible promissory note and recorded in equity at their relative fair values with a corresponding debt discount recorded to ASOP Note II. The principal balance outstanding at March 31, 2024 was $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ASOPNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesPartnersOneLPMember_zQEK9XMnU7d2" title="Debt instrument principal reduction payment">1,073,250</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the Company entered into a convertible promissory note (“ASOF Note II”) with Arena Special Opportunities Fund, LP. The principal balance of the note is $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20210531__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_z64KL03wijP3" title="Total notes and loans payable">306,865</span> and it is to be utilized for working capital purposes. The note matures on <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20210501__20210531__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zZ33OFTO8y47" title="Debt instrument, maturity date">January 31, 2022</span> and all principal, accrued and unpaid interest is due at maturity at a rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210531__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zxCZpTWRwKLa" title="Debt instrument, interest rate">12</span>% per annum. The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered a derivative and therefore has been recorded in liabilities as part of the convertible promissory note and not bifurcated. In addition, the ASOP convertible promissory note was issued with <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210501__20210531__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zmB8hpbmFZld" title="Number of shares issued">26,228</span> common stock warrants. The common stock purchase warrants entitle the holder to purchase an aggregate of up to <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210531__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zpTNTmi2RsUd" title="Number of shares issued">26,228</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210531__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zqKAqpcisppk" title="Warrants exercise price">6.75</span> per share. The common stock purchase warrants issued to ASOF are considered derivatives, but satisfied the criteria for classification as equity instruments, and were bifurcated from the host contract - convertible promissory note and recorded in equity at their relative fair values with a corresponding debt discount recorded to ASOF Note II. The principal balance outstanding at March 31, 2024 was $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIIMember__dei--LegalEntityAxis__custom--ArenaSpecialOpportunitiesFundLPMember_zpqbacSYD1Yh" title="Debt instrument principal reduction payment">276,750</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maturity dates for the above notes were extended to April 30, 2022 on April 14, 2022 in exchange for the Company’s promise to pay the holders $<span id="xdx_900_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20220414__20220414__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIIMember__srt--TitleOfIndividualAxis__custom--HoldersMember_zJh1beilXXq7">300,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. <span id="xdx_907_eus-gaap--DebtInstrumentPaymentTerms_c20220414__20220414__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIIMember__srt--TitleOfIndividualAxis__custom--HoldersMember_z4Ll9mbJgDV">The holders agreed to allow the Company to extend the notes for two additional 30-day periods for $100,000 per extension. The holders also waived certain defaults under the notes.</span></span> <span id="xdx_906_ecustom--RepaymentsOfRelatedPartyDebtAdditional_c20220414__20220414__us-gaap--DebtInstrumentAxis__custom--ASOFNoteIIMember__srt--TitleOfIndividualAxis__custom--HoldersMember_zVEHS6Ywluo2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company subsequently elected to extend the maturity date to May 31, 2022 for the promise to pay an additional $100,000.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As discussed below under “Forbearance and Amendment of Outstanding Notes,” ASOP and ASOF have agreed to forbear from exercising remedies under the notes until December 31, 2023 provided that the Company does not default on its obligations under the Forbearance Agreement. In September 2023, Arena notified the Company that it was in default of certain obligations under the Forbearance Agreement but did not declare an acceleration of the indebtedness. In April 2024, Arena instituted a lawsuit seeking, among other things, a declaratory judgment that the Company is in breach of the Arena notes and Forbearance Agreement. On March 14, 2024, an auction of the assets of the Company’s hemp division was conducted under Article 9 of the Uniform Commercial Code following allegations by Arena that the Company was in breach of its obligations under certain notes and a forbearance agreement. See “Part II Item 1. Legal Proceedings.”</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024 </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2022, the Company entered into a convertible promissory note (“Empire Note”) with Empire Properties, LLC (“Empire”). The principal balance of the note is $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220101__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__dei--LegalEntityAxis__custom--EmpirePropertiesLLCMember_zumQM8oFLZng" title="Total notes and loans payable">52,319</span> and it is to be utilized for working capital purposes. The note matured on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20220101__20220101__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__dei--LegalEntityAxis__custom--EmpirePropertiesLLCMember_zvOaV59X77Ef" title="Debt instrument, maturity date">December 31, 2022</span> or due on demand subsequently to any major funding received by the Company in excess of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_c20220101__20220101__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__dei--LegalEntityAxis__custom--EmpirePropertiesLLCMember_zBLK0Ojbpg05" title="Principal funding received">5,000,000</span> and all principal, accrued and unpaid interest is due at maturity at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220101__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__dei--LegalEntityAxis__custom--EmpirePropertiesLLCMember_zM9TxNHG45ak" title="Debt instrument, interest rate">8</span>% per annum. The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered a derivative and therefore has been recorded in liabilities as part of the convertible promissory note and not bifurcated. The principal balance outstanding at March 31, 2024 was $<span id="xdx_90E_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pp0p0_c20240101__20240331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember__dei--LegalEntityAxis__custom--EmpirePropertiesLLCMember_z6b6NfPgNiUk" title="Debt instrument principal reduction payment">52,319</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2022, the Company entered into a convertible promissory note (“BL Note”) with Blue Lake Partners, LLC (“BL”). The original principal amount of the note was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--BLNoteMember__dei--LegalEntityAxis__custom--BlueLakePartnersLLCMember_zdMaxaxJdo9" title="Debt instrument, face amount">250,000</span> and the proceeds are to be utilized for working capital purposes. The note had an original maturity date of <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20220301__20220331__us-gaap--DebtInstrumentAxis__custom--BLNoteMember__dei--LegalEntityAxis__custom--BlueLakePartnersLLCMember_zzEzLSmSj3Kc" title="Debt instrument, maturity date">March 22, 2023</span> and all principal, accrued and unpaid interest is due at maturity at a rate of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220331__us-gaap--DebtInstrumentAxis__custom--BLNoteMember__dei--LegalEntityAxis__custom--BlueLakePartnersLLCMember_zOUzE18MNsj1" title="Debt instrument, interest rate">12</span>% per annum. The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered a derivative and therefore has been recorded in liabilities as part of the convertible promissory note and not bifurcated. In addition, the BL Note was issued with <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220301__20220331__us-gaap--DebtInstrumentAxis__custom--BLNoteMember__dei--LegalEntityAxis__custom--BlueLakePartnersLLCMember_zmUCI2R7P8h6" title="Number of shares issued">39,062</span> common stock warrants. The common stock purchase warrants entitle the holder to purchase an aggregate of up to <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220331__us-gaap--DebtInstrumentAxis__custom--BLNoteMember__dei--LegalEntityAxis__custom--BlueLakePartnersLLCMember_zDweDFz5JW42" title="Warrants to purchase common stock">39,062</span> shares of the Company’s common stock at an initial exercise price of $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--BLNoteMember__dei--LegalEntityAxis__custom--BlueLakePartnersLLCMember_zyznIxjJ4Drl" title="Warrants exercise price">6.40</span> per share (subject to adjustment upon the occurrence of certain events, including the issuance of lower priced securities). The common stock purchase warrants issued to BL are considered derivatives and did not satisfy the criteria for classification as equity instruments and were bifurcated from the host contract - convertible promissory note and recorded as a liability at fair value with a corresponding debt discount recorded to the BL Note with subsequent changes in fair values recognized in the consolidated statement of operations at each reporting date. Effective February 27, 2023, in consideration of the Company repaying an aggregate of $<span id="xdx_905_eus-gaap--RepaymentsOfDebt_c20230227__20230227__us-gaap--DebtInstrumentAxis__custom--BLNoteMember__dei--LegalEntityAxis__custom--BlueLakePartnersLLCMember_zzyzfU1iW54k" title="Repayments of debt">66,667</span> under the BL Note, BL agreed to extend the maturity date of the BL Note until September 1, 2023 and reduce the percentage of the cash proceeds received by the Company from the issuance of equity or debt that BL can require the Company to apply to the repayment of the BL Note from <span id="xdx_902_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20230227__20230227__us-gaap--DebtInstrumentAxis__custom--BLNoteMember__dei--LegalEntityAxis__custom--BlueLakePartnersLLCMember__srt--RangeAxis__srt--MaximumMember_zmp1QIW9oYYe" title="Debt instrument, variable rate">50</span>% to<span id="xdx_906_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20230227__20230227__us-gaap--DebtInstrumentAxis__custom--BLNoteMember__dei--LegalEntityAxis__custom--BlueLakePartnersLLCMember__srt--RangeAxis__srt--MinimumMember_ze3mBi8eKEx7" title="Debt instrument, variable rate"> 33</span>%. The principal balance outstanding at March 31, 2024 was $<span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--BLNoteMember__dei--LegalEntityAxis__custom--BlueLakePartnersLLCMember_zPcKnlTgW2Y2" title="Debt instrument principal reduction payment">102,623</span> and the BL Note is past due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2022, the Company entered into a convertible promissory note (“MH Note”) with Mast Hill Fund, LP (“MH”). The original principal amount of the note was $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--MHNoteMember__dei--LegalEntityAxis__custom--MastHillFundLPMember_zSyT1RKq9gXj" title="Debt instrument, face amount">350,000</span> and the proceeds are to be utilized for working capital purposes. The note had an original maturity date of <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20220301__20220331__us-gaap--DebtInstrumentAxis__custom--MHNoteMember__dei--LegalEntityAxis__custom--MastHillFundLPMember_zWOhaI42JIf2" title="Debt instrument, maturity date">March 22, 2023</span> and all principal, accrued and unpaid interest is due at maturity at a rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220331__us-gaap--DebtInstrumentAxis__custom--MHNoteMember__dei--LegalEntityAxis__custom--MastHillFundLPMember_zP5yGjnpCGyl" title="Debt instrument, interest rate">12</span>% per annum. The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered a derivative and therefore has been recorded in liabilities as part of the convertible promissory note and not bifurcated. In addition, the MH Note was issued with <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220301__20220331__us-gaap--DebtInstrumentAxis__custom--MHNoteMember__dei--LegalEntityAxis__custom--MastHillFundLPMember_zzBJ2iKpOruc" title="Number of shares issued">39,062</span> common stock warrants. The common stock purchase warrants entitle the holder to purchase an aggregate of up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20220331__us-gaap--DebtInstrumentAxis__custom--MHNoteMember__dei--LegalEntityAxis__custom--MastHillFundLPMember_zptD7iWOZugk" title="Warrants to purchase common stock">39,062</span> shares of the Company’s common stock at an initial exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--MHNoteMember__dei--LegalEntityAxis__custom--MastHillFundLPMember_zN3zuczwc8yk" title="Warrants exercise price">6.40</span> per share (subject to adjustment upon the occurrence of certain events, including the issuance of lower priced securities). The common stock purchase warrants issued to MH are considered derivatives and did not satisfy the criteria for classification as equity instruments and were bifurcated from the host contract - convertible promissory note and recorded as a liability at fair value with a corresponding debt discount recorded to the MH Note with subsequent changes in fair values recognized in the consolidated statement of operations at each reporting date. Effective February 27, 2023, in consideration of the Company repaying an aggregate of $<span id="xdx_90E_eus-gaap--RepaymentsOfDebt_c20230227__20230227__us-gaap--DebtInstrumentAxis__custom--MHNoteMember__dei--LegalEntityAxis__custom--MastHillFundLPMember_zVb9xGj0IXFj" title="Repayments of debt">93,333</span> under the MH Note, MH agreed to extend the maturity date of the MH Note until September 1, 2023 and reduce the percentage of the cash proceeds received by the Company from the issuance of equity or debt that MH can require the Company to apply to the repayment of the MH Note from <span id="xdx_908_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20230227__20230227__us-gaap--DebtInstrumentAxis__custom--MHNoteMember__dei--LegalEntityAxis__custom--MastHillFundLPMember__srt--RangeAxis__srt--MaximumMember_zLCdBqSOF8Eb" title="Debt instrument, variable rate">50</span>% to <span id="xdx_908_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20230227__20230227__us-gaap--DebtInstrumentAxis__custom--MHNoteMember__dei--LegalEntityAxis__custom--MastHillFundLPMember__srt--RangeAxis__srt--MinimumMember_zx7fbMQXYx35" title="Debt instrument, variable rate">33</span>%. . The principal balance outstanding at March 31, 2024 was $<span id="xdx_903_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--MHNoteMember__dei--LegalEntityAxis__custom--MastHillFundLPMember_zjqGtHnSK2Ag" title="Debt instrument principal reduction payment">256,667</span> and the MH Note is past due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2022, the Company entered into a convertible promissory note (“FM Note”) with Fourth Man, LLC (“FM”). The original principal amount of the note was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20220430__us-gaap--DebtInstrumentAxis__custom--FMNoteMember__dei--LegalEntityAxis__custom--FourthManLLCMember_z5GcMyZcwNpf" title="Debt instrument, face amount">150,000</span> and the proceeds are to be utilized for working capital purposes. The note had an original maturity date of <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20220401__20220430__us-gaap--DebtInstrumentAxis__custom--FMNoteMember__dei--LegalEntityAxis__custom--FourthManLLCMember_zKExO4W5AMh4" title="Debt instrument, maturity date">April 22, 2023</span> and all principal, accrued and unpaid interest is due at maturity at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220430__us-gaap--DebtInstrumentAxis__custom--FMNoteMember__dei--LegalEntityAxis__custom--FourthManLLCMember_zQtZNaOvbX2k" title="Debt instrument, interest rate">12</span>% per annum. The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered derivatives and therefore have been recorded in liabilities as part of the convertible promissory note and not bifurcated. In addition, the FM Note was issued with <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220401__20220430__us-gaap--DebtInstrumentAxis__custom--FMNoteMember__dei--LegalEntityAxis__custom--FourthManLLCMember_zUnRcnZzXCHi" title="Number of shares issued">23,437</span> common stock warrants. The common stock purchase warrants entitle the holder to purchase an aggregate of up to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220430__us-gaap--DebtInstrumentAxis__custom--FMNoteMember__dei--LegalEntityAxis__custom--FourthManLLCMember_zOFDESc43eGg" title="Warrants to purchase common stock">23,437</span> shares of the Company’s common stock at an initial exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220430__us-gaap--DebtInstrumentAxis__custom--FMNoteMember__dei--LegalEntityAxis__custom--FourthManLLCMember_zQ8weBtziya3" title="Warrants exercise price">6.40</span> per share (subject to adjustment upon the occurrence of certain events, including the issuance of lower priced securities). The common stock purchase warrants issued to FM are considered derivatives and did not satisfy the criteria for classification as equity instruments and were bifurcated from the host contract - convertible promissory note and recorded as a liability at fair value with a corresponding debt discount recorded to the FM Note with subsequent changes in fair values recognized in the consolidated statement of operations at each reporting date. Effective February 27, 2023, in consideration of the Company repaying an aggregate of $<span id="xdx_90B_eus-gaap--RepaymentsOfDebt_c20230227__20230227__us-gaap--DebtInstrumentAxis__custom--FMNoteMember__dei--LegalEntityAxis__custom--FourthManLLCMember_zEIrfbGS3ZNj" title="Repayments of debt">40,000</span> under the FM Note, FM agreed to extend the maturity date of the FM Note until September 1, 2023 and reduce the percentage of the cash proceeds received by the Company from the issuance of equity or debt that FM can require the Company to apply to the repayment of the FM Note from <span id="xdx_90D_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20230227__20230227__us-gaap--DebtInstrumentAxis__custom--FMNoteMember__dei--LegalEntityAxis__custom--FourthManLLCMember__srt--RangeAxis__srt--MaximumMember_z2Ut7r1GZT79" title="Debt instrument, variable rate">50</span>% to <span id="xdx_902_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20230227__20230227__us-gaap--DebtInstrumentAxis__custom--FMNoteMember__dei--LegalEntityAxis__custom--FourthManLLCMember__srt--RangeAxis__srt--MinimumMember_zpdZamIol5T4" title="Debt instrument, variable rate">33</span>%. On June 30^th, 2023 the Company entered into a Settlement and Mutual Release Agreement to extinguish the $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--FMNoteMember__dei--LegalEntityAxis__custom--FourthManLLCMember_zMDIDd5IRfz5" title="Debt instrument principal reduction payment">110,000</span> principal outstanding on the FM Note. As of March 31, 2024 the FM Note had been satisfied in full.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2022, the Company entered into a convertible promissory note (“Alumni Note”) with Alumni Capital, LP (“Alumni”). The original principal amount of the note was $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20220630__us-gaap--DebtInstrumentAxis__custom--AlumniNoteMember__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zGZViiBAhTub" title="Debt instrument, face amount">62,500</span> and the proceeds are to be utilized for working capital purposes. The note had an original maturity date of <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_c20220601__20220630__us-gaap--DebtInstrumentAxis__custom--AlumniNoteMember__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zLCLp5LI5AQf" title="Debt instrument, maturity date">June 6, 2023</span> which was extended until September 1, 2023 effective February 27, 2023. All principal, accrued and unpaid interest is due at maturity at a rate of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220630__us-gaap--DebtInstrumentAxis__custom--AlumniNoteMember__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zBvsHrbYqTX4" title="Debt instrument, interest rate">12</span>% per annum. The holder can require the full payment of the note if the Company completes an offering of its common stock that results in an uplisting of its common stock to a national securities exchange. The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered derivatives and therefore have been recorded in liabilities as part of the convertible promissory note and not bifurcated. In addition, the Alumni Note was issued with <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220601__20220630__us-gaap--DebtInstrumentAxis__custom--AlumniNoteMember__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zpStCkR8Xtwj" title="Number of shares issued">9,766</span> common stock warrants. The common stock purchase warrants entitle the holder to purchase an aggregate of up to <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220630__us-gaap--DebtInstrumentAxis__custom--AlumniNoteMember__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zSFpQTGV2tha" title="Warrants to purchase common stock">9,766</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220630__us-gaap--DebtInstrumentAxis__custom--AlumniNoteMember__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zI9YDxaVKZze" title="Warrants exercise price">6.40</span> per share. The common stock purchase warrants issued to Alumni are considered derivatives and did not satisfy the criteria for classification as equity instruments and were bifurcated from the host contract - convertible promissory note and recorded as a liability at fair value with a corresponding debt discount recorded to the Alumni Note with subsequent changes in fair values recognized in the consolidated statement of operations at each reporting date. The principal balance outstanding at March 31, 2024 was $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--AlumniNoteMember__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zUXFulNSFTnf" title="Debt instrument principal reduction payment">62,500</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2022, the Company entered into a convertible promissory note (“WN”) with Walleye Opportunities Master Fund Ltd. (“WOMF”). The original principal amount of the note was $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20220831__dei--LegalEntityAxis__custom--WalleyeOpportunitiesMasterFundMember__us-gaap--DebtInstrumentAxis__custom--WalleyeOpportunitiesMasterFundNoteMember_zaYMYCYAQC94" title="Debt instrument, face amount">385,000</span> and the proceeds are to be utilized for working capital purposes. The note originally matured on <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20220801__20220831__dei--LegalEntityAxis__custom--WalleyeOpportunitiesMasterFundMember__us-gaap--DebtInstrumentAxis__custom--WalleyeOpportunitiesMasterFundNoteMember_zaTsJFi4Eda4" title="Debt instrument, maturity date">August 30, 2023</span> and all principal, accrued and unpaid interest is due at maturity at a rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220831__dei--LegalEntityAxis__custom--WalleyeOpportunitiesMasterFundMember__us-gaap--DebtInstrumentAxis__custom--WalleyeOpportunitiesMasterFundNoteMember_zOJtUWzX8L25" title="Debt instrument, interest rate">12</span>% per annum. The conversion options contained in the convertible promissory note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered derivatives and therefore have been recorded in liabilities as part of the convertible promissory note and not bifurcated. In addition, the WN Note was issued with <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220801__20220831__us-gaap--DebtInstrumentAxis__custom--WalleyeOpportunitiesMasterFundNoteMember__dei--LegalEntityAxis__custom--WalleyeOpportunitiesMasterFundMember_zyAtKwIRfEXh" title="Number of shares issued">71,296</span> common stock warrants. The common stock purchase warrants entitle the holder to purchase an aggregate of up to <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220831__us-gaap--DebtInstrumentAxis__custom--WalleyeOpportunitiesMasterFundNoteMember__dei--LegalEntityAxis__custom--WalleyeOpportunitiesMasterFundMember_zhQO1x40yjbe" title="Warrants to purchase common stock">71,296</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220831__us-gaap--DebtInstrumentAxis__custom--WalleyeOpportunitiesMasterFundNoteMember__dei--LegalEntityAxis__custom--WalleyeOpportunitiesMasterFundMember_zkdKclmNK4ok" title="Warrants exercise price">5.40</span> per share. The common stock purchase warrants issued to WOMF are considered derivatives and did not satisfy the criteria for classification as equity instruments and were bifurcated from the host contract - convertible promissory note and recorded as a liability at fair value with a corresponding debt discount recorded to the WN with subsequent changes in fair values recognized in the consolidated statement of operations at each reporting date. The principal balance outstanding at March 31, 2024 was $<span id="xdx_90F_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--WalleyeOpportunitiesMasterFundNoteMember__dei--LegalEntityAxis__custom--WalleyeOpportunitiesMasterFundMember_ztEkc1HU65Da" title="Debt instrument principal reduction payment">385,000</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2023 the Company entered into a convertible promissory note (“Tysadco Note VI”) with Tysadco Partners, LLC (“Tysadco”). The original principal amount of the note was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20230131__dei--LegalEntityAxis__custom--TysadcoPartnersMember__us-gaap--DebtInstrumentAxis__custom--TysadcoNoteVIMember_zjHyLK7d1on7" title="Debt instrument, face amount">100,000</span> and the proceeds are to be utilized for working capital purposes. The note had a maturity date of <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_dd_c20230101__20230131__us-gaap--DebtInstrumentAxis__custom--TysadcoNoteVIMember__dei--LegalEntityAxis__custom--TysadcoPartnersMember_zrj6tMA3ZBI1" title="Debt instrument, maturity date">April 12, 2023</span>, and all principal, accrued and unpaid interest is due at maturity at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230131__dei--LegalEntityAxis__custom--TysadcoPartnersMember__us-gaap--DebtInstrumentAxis__custom--TysadcoNoteVIMember_zA3A9ACzYFjd" title="Debt instrument, interest rate">12</span>% per annum. Effective January 31, 2023, Tysadco agreed to exchange the Tysdaco Note VI and other notes held by Tysdaco in the aggregate principal amount of $<span id="xdx_90D_eus-gaap--ConvertibleLongTermNotesPayable_iI_c20230131__dei--LegalEntityAxis__custom--TysadcoPartnersMember__us-gaap--DebtInstrumentAxis__custom--TysadcoNoteVIMember_zo6kAUmVVtF3" title="Debt exchange amount">752,000</span> having maturity dates between August 24, 2022 and March 19, 2023 for a single note that matured on September 1, 2023. Contemporaneous with this exchange, Tysadco assigned the combined note to ClearThink Capital Partners, LLC and the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_dd_c20230101__20230131__us-gaap--DebtInstrumentAxis__custom--TysadcoNoteVIMember__dei--LegalEntityAxis__custom--TysadcoPartnersMember_zDgPNHvSps4b" title="Number of shares issued">130,000</span> shares of common stock to ClearThink Capital Partners, LLC. The conversion options contained in the combined note were evaluated for derivative accounting under ASC 815, Derivatives and Hedging, and determined not to be considered derivatives and therefore have been recorded in liabilities as part of the convertible promissory note and not bifurcated. The principal balance of the combined note at March 31, 2024 was $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--TysadcoNoteVIMember__dei--LegalEntityAxis__custom--TysadcoPartnersMember_zACjXQXgEXq9" title="Debt instrument principal reduction payment">1,007,500</span> and the combined note is past due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 2, 2023, the Company completed the sale of a promissory note (the “Note”) in the principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20230302__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--WOMFMember_zVpTwJuJHZE4" title="Debt instrument face amount">1,823,529</span> to WOMF pursuant to a Securities Purchase Agreement dated as of February 27, 2023. The purchase price of the Note was $<span id="xdx_903_eus-gaap--DebtInstrumentIssuedPrincipal_c20230302__20230302__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--WOMFMember_zv3B7KjZQhFk" title="Debt instrument purchase amount">1,550,000</span>, representing a <span id="xdx_906_eus-gaap--DebtConversionOriginalDebtInterestRateOfDebt_pid_dp_uPure_c20230302__20230302__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--WOMFMember_zq0KY8eZu9rk" title="Original debt, interest rate">15</span>% original issue discount. The Note is non-interest bearing, except in the case of the event of a default, in which case interest will accrue from the date of the default at a rate equal to the lower of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20230302__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RangeAxis__srt--MaximumMember_zRF7fInKzSf" title="Debt instrument interest rate percentage">18</span>% per annum or the maximum rate permitted by law.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Note is payable in nine (9) monthly installments of $<span id="xdx_909_eus-gaap--DebtInstrumentPeriodicPayment_c20230302__20230302__dei--LegalEntityAxis__custom--WOMFMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z95JVMfEqt3c" title="Debt instrument periodic payment">232,500</span> each, consisting of a $<span id="xdx_90A_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20230302__20230302__dei--LegalEntityAxis__custom--WOMFMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zknjzAMzScQ5" title="Debt instrument principal reduction payment">227,941</span> principal reduction payment and a $<span id="xdx_909_ecustom--RedemptionFee_iI_c20230302__dei--LegalEntityAxis__custom--WOMFMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zLTIlz9kKpSb" title="Redemption fee">4,559</span> redemption fee, commencing on April 27, 2023. The Company’s obligations under the note are secured by a security interest in the Company’s deposit accounts and the deposit accounts of the Company’s subsidiaries. In addition, each the Company’s subsidiaries has agreed that if an event of default occurs under the Note, the subsidiary will pay to WOMF an amount equal to <span id="xdx_901_eus-gaap--RevenueRemainingPerformanceObligationPercentage_iI_pid_dp_uPure_c20230302__dei--LegalEntityAxis__custom--WOMFMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zEzg8BnbqO41" title="Revenue, percentage">10</span>% of revenues received during the prior month from the sale of goods or services or collections of accounts receivable. In connection with this Note, the Company issued a warrant for <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230302_zig38u2P0KCk" title="Number of warrants issued">1,823,529</span> shares. These warrants have <span id="xdx_90D_eus-gaap--FairValueAdjustmentOfWarrants_do_c20230302__20230302_zqTMfGBvmqEb" title="Intrinsic value of warrants">no</span> intrinsic value and their fair value is insignificant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Note requires the Company to use reasonable commercial efforts to complete an offering which will result in an uplisting of its common stock to a national securities exchange within a reasonable time following the issuance of the Note. The Note contains certain negative covenants, including a prohibition on the incurrence of debt that is senior or <i>pari passu</i> to the indebtedness represented by the Note, the creation of liens on the Company’s assets, the payment of dividends and other distributions on the Company’s common stock, the repurchase of the Company’s common stock, the sale of a significant portion of the Company’s assets and the repayment of indebtedness other than existing indebtedness.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may elect to pay all or a portion of a monthly installment due under the Note by converting such amount into shares of the Company’s common stock at a price of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20230302__dei--LegalEntityAxis__custom--WOMFMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEmNHSEXquc6" title="Convertible conversion price">4.00</span> per share, subject to adjustment in accordance with the terms of the Note. As of March 31, 2023, the adjusted conversion price was $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20230930__dei--LegalEntityAxis__custom--WOMFMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z40F3q9gsxV6" title="Convertible conversion price">.0772</span>. If the Company does not pay an installment when due it is deemed an election by the Company to convert the installment payment into common stock at a price equal to the lower of $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20230302__dei--LegalEntityAxis__custom--WOMFMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MinimumMember_zh0kvsT8FRAj" title="Convertible conversion price">4.00</span> per share or <span id="xdx_900_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20230302__20230302__dei--LegalEntityAxis__custom--WOMFMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpvAq4sSkele" title="Lowest daily volume weighted average price">90</span>% of the lowest daily volume weighted average price of the common stock during the five trading days preceding the conversion date. WOMF has the right to determine the timing of any such conversion. WOMF may elect at any time to convert amounts payable under the Note into shares of the Company’s common stock at a conversion price of $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20230302__dei--LegalEntityAxis__custom--WOMFMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfmMLnq4qHRj" title="Conversion price per share">4.00</span> per share, subject to adjustment in accordance with the terms of the Note. The Company has not paid any of the monthly installments due under the Note in cash. As a result, these installment payments were converted into common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company receives cash proceeds from any source, including payments from customers or from the issuance of equity or debt, WOMF can require the Company to apply 100% of such proceeds to the repayment of the Note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company completes a placement of securities, WOMF will have the right to accept such new securities in lieu of the Note and Warrant. For so long as the Note is outstanding, if the Company issues a security or amends the terms of a security issued before the issue date of the Note, and WOMF believes that terms of the new or amended security are more favorable to the holder than the terms provided to WOMF, WOMF may require that such terms become part of WOMF’s transaction documents with the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of a default under the Note, the Company shall be required to pay WOMF an amount equal to the amount determined by multiplying the principal amount then outstanding plus default interest by <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230302__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z987sPYQkpph" title="Debt instrument interest rate stated percentage">135</span>%, plus costs of collection. WOMF may elect to accept payment of any such amount in cash and/or shares of the Company’s common stock, valued for this purpose at the lower of the conversion price then in effect or a <span id="xdx_908_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20230302__20230302__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zeRriTxEj8Be" title="Debt instrument convertible percentage">60</span>% discount to the lowest volume weighted average price of the common stock during the five trading days preceding the conversion date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WOMF has been granted a right of first refusal to participate in future financing transactions conducted by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As additional consideration for the purchase of the Note, the Company issued WOMF a warrant (the “Warrant”) to purchase <span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_c20230302__20230302__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zXmeQKZk7xQb" title="Stock repurchased during period shares">1,307,190</span> shares of the Company’s common stock at an exercise price equal to <span id="xdx_901_ecustom--PercentageOfVolumeWeightedAveragePrice_pid_dp_uPure_c20230302__20230302__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z9nKNFArrfEi" title="Percentage of volume weighted average price">90</span>% of the lowest volume weighted average price of the common stock during the five trading days preceding the date of exercise. The Warrant contains a cashless exercise provision and is exercisable at any time during the period beginning on August 27, 2023 and ending on August 27, 2028. In addition, a warrant issued by the Company to WOMF in August 2022 was amended to change the exercise price of the warrant from $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230302__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RangeAxis__srt--MinimumMember_zqEIrcfsc4Vh" title="Exercise price">5.40</span> per share to the lower of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230302__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__srt--RangeAxis__srt--MaximumMember_zwsm7E6xbiv" title="Exercise price">5.40</span> per share or the lowest volume weighted average price of the common stock during the five trading days preceding its exercise.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into a Registration Rights Agreement with WOMF pursuant to which the Company has agreed to file a registration statement with the Securities and Exchange Commission to register the shares of common stock issuable upon the conversion of the Note and the exercise of the Warrant for public resale. The Company filed the registration statement on May 12, 2023 and it was declared effective on May 22, 2023. WOMF has also been granted piggyback registration rights with respect to the shares of common stock issuable upon the conversion of the Note and the exercise of the Warrant. Each of the Note and Warrant grants full ratchet anti-dilution protection to WOMF in the event that the Company issues common stock or rights to purchase common stock at a price less than the conversion or exercise price then in effect.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2023, the Company issued a promissory note to WOMF in the principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20230531__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zonSYd8VUQz9" title="Total notes and loans payable">437,500</span>. The purchase price of the note was $<span id="xdx_90D_ecustom--PurchaseAmountOfFutureReceivables_c20230501__20230531__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zlsahFQEyNhj" title="Debt instrument purchase amount">350,000</span>, representing a <span id="xdx_90D_ecustom--DebtInstrumentDiscountPercentage_iI_pid_dp_uPure_c20230531__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z064X3iaCZ0b" title="Debt instrument discount percentage">20</span>% original issue discount. The note is non-interest bearing except in the event of a default, in which case interest will accrue at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230501__20230531__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z8yX953YuQgh" title="Debt Instrument interest rate">40</span>% per annum in the event of a payment default and <span id="xdx_904_eus-gaap--DebtInstrumentBasisSpreadOnVariableRate1_pid_dp_uPure_c20230501__20230531__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zz9AmZ9Xw4u1" title="Debt Instrument, percentage">18</span>% per annum in the event of other defaults. The note became due on October 15, 2023. The principal balance outstanding at March 31, 2024 was $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_c20240101__20240331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z8G8q52AchJ3" title="Debt instrument principal reduction payment">256,893</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Forbearance and Amendment of Outstanding Notes</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contemporaneous with the sale of the Note and Warrant to WOMF, ASOP and ASOF (collectively, “Arena”), who hold promissory notes with an unpaid principal balance of approximately $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230531__us-gaap--TypeOfArrangementAxis__custom--ForbearanceAgreementMember_zFNKjBvcoEHl" title="Debt face amount">3,877,000</span> which became due on April 30, 2022 (the “Arena Notes”), entered into a Forbearance Agreement with the Company pursuant to which they agreed to forbear from exercising remedies under the Arena Notes until December 31, 2024 provided that the Company does not default on its obligations under the Forbearance Agreement. In September 2023, Arena notified the Company that it was in default of certain obligations under the Forbearance Agreement but did not declare an acceleration of the indebtedness.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Forbearance Agreement requires the Company and/or Company’s subsidiaries, Duramed, Inc. and Duramed MI, LLC (together the “Duramed Subsidiaries<b>”) </b>to remit to Arena on a monthly basis certain accounts receivable collected by the Company and/or the Duramed Subsidiaries until the total amount collected is $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfDebt_c20230501__20230531__us-gaap--TypeOfArrangementAxis__custom--ForbearanceAgreementMember__dei--LegalEntityAxis__custom--DuramedMILLCMember_zBrEyyWnJZC4" title="Proceeds from issuance of debt">5,700,000</span>. After the amount collected is $<span id="xdx_90D_eus-gaap--ProceedsFromCollectionOfNotesReceivable_c20230501__20230531__us-gaap--TypeOfArrangementAxis__custom--ForbearanceAgreementMember__dei--LegalEntityAxis__custom--DuramedMILLCMember_zzkuKo42PRif" title="Proceeds from collection of notes receivable">5,700,000</span>, additional collections of these receivables are shared equally between the Company and Arena. The Company and the Duramed Subsidiaries have assigned their rights to these receivables to Arena.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If Arena fully exercises warrants to purchase shares of the Company’s common stock that were previously issued to it, and the aggregate market value of the shares acquired is less than $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230501__20230531__us-gaap--TypeOfArrangementAxis__custom--ForbearanceAgreementMember__dei--LegalEntityAxis__custom--DuramedMILLCMember_zd8eE3wYUIUe" title="Stock issued during period value acquisitions">1,500,000</span>, the Company must pay to Arena an amount equal to such difference.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023 Arena notified the Company that it intended to conduct an auction of certain of the Company’s assets under Article 9 of the Uniform Commercial Code due to the alleged breaches of the Forbearance Agreement. The auction took place on March 14, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a condition to the closing of the sale of the Note and Warrant to the WOMF, certain terms of certain promissory notes previously issued by the Company were amended, including the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in consideration of an increase in the aggregate principal amount by $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230531__srt--TitleOfIndividualAxis__custom--HolderMember__dei--LegalEntityAxis__custom--WOMFMember_zArwsIYiX7D3" title="Debt instrument face amount">10,000</span> and an increase in the interest rate to <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230531__srt--TitleOfIndividualAxis__custom--HolderMember__dei--LegalEntityAxis__custom--WOMFMember_z8AOraahYuz7" title="Interest rate">18</span>% per annum, the holder of notes in the aggregate principal amount of $<span id="xdx_902_ecustom--RepaymentsOfPrincipalAmount_c20230501__20230531__srt--TitleOfIndividualAxis__custom--HolderMember__dei--LegalEntityAxis__custom--WOMFMember_z7hpxwH6Y0df" title="Repayments of principal amount">150,000</span> agreed to waive his right to require the Company to repay a $<span id="xdx_904_eus-gaap--RepaymentsOfNotesPayable_c20230501__20230531__srt--TitleOfIndividualAxis__custom--HolderMember__dei--LegalEntityAxis__custom--WOMFMember_z44xhEduf122" title="Repayments of debt">50,000</span> note upon the Company’s receipt of $<span id="xdx_901_eus-gaap--DebtDefaultLongtermDebtAmount_iI_c20230531__srt--TitleOfIndividualAxis__custom--HolderMember__dei--LegalEntityAxis__custom--WOMFMember_zJjCy0x4Vnvh" title="Debt default longterm debt amount">1,500,000</span> of financing and extend maturity dates from November 18, 2021 and January 22, 2023 to September 1, 2023;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in consideration of the Company’s agreement to provide a product credit for future orders of $<span id="xdx_90C_eus-gaap--LineOfCredit_iI_c20230531__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__dei--LegalEntityAxis__custom--WOMFMember_z080nzV3kM37" title="Line of credit">50,000</span>, the holder of a promissory note in the principal amount of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230531__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__dei--LegalEntityAxis__custom--WOMFMember_zyGIpigeAhyg" title="Debt instrument face amount">150,000</span> agreed to extend the maturity date from August 10, 2022 to September 1, 2023;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the maturity date of a promissory note in the principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20230531__dei--LegalEntityAxis__custom--WOMFMember_zCBeubgXGq52" title="Debt instrument face amount">1,250,000</span> was extended from August 12, 2022 until the earlier of September 1, 2023 or the date that the Company completes an offering resulting in an uplisting of its common stock to the Nasdaq Capital Market; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in consideration of the repayment of a total of $<span id="xdx_90D_eus-gaap--RepaymentsOfDebt_c20230501__20230531__srt--TitleOfIndividualAxis__custom--HolderMember__dei--LegalEntityAxis__custom--WOMFMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zbDOhj337ZO2" title="Repayments of debt">232,500</span> under the notes, the holders of promissory notes in the aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20230531__srt--TitleOfIndividualAxis__custom--HolderMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__dei--LegalEntityAxis__custom--WOMFMember_zX5CDYTNstyk" title="Debt instrument face amount">435,000</span> issued in October and November 2022 that bore interest at <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230531__dei--LegalEntityAxis__custom--WOMFMember__srt--TitleOfIndividualAxis__custom--HolderMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zJf4Hp1Lf0Oe" title="Debt instrument interest rate stated percentage">18</span>% per annum and were past due agreed to exchange the notes for new notes that matured on September 1, 2023 and bear interest at <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20230501__20230531__srt--TitleOfIndividualAxis__custom--HolderMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember__dei--LegalEntityAxis__custom--WOMFMember_zkS4UPpAAR7c" title="Debt instrument, interest rate">15</span>% per annum;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>TWS Note</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 12, 2021, pursuant to an Equipment Acquisition Agreement, the Company entered into a twelve-month promissory note of $<span id="xdx_905_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_c20210812__us-gaap--TypeOfArrangementAxis__custom--EquipmentAcquisitionAgreementMember_zRlCVlMZSonf" title="Total notes and loans payable">1,250,000</span> with payments of $<span id="xdx_908_eus-gaap--DebtInstrumentPeriodicPayment_pp0p0_c20210811__20210812__us-gaap--TypeOfArrangementAxis__custom--EquipmentAcquisitionAgreementMember_zelRimOjlj3f" title="Debt monthly payments due">100,000</span> per month and interest at <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210812__us-gaap--TypeOfArrangementAxis__custom--EquipmentAcquisitionAgreementMember_z1lPUOQ79ewe" title="Debt instrument, interest rate">6</span>% (See Note 5). As of March 31, 2024, the total amount outstanding was $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20240331__us-gaap--TypeOfArrangementAxis__custom--EquipmentAcquisitionAgreementMember_zLIenfhohera" title="Debt outstanding">1,050,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">WOMF October 2023 Note</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 27, 2023, the Company completed the sale of a promissory note (the “Initial Note”) in the principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20231027__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zWCCkvZZcMc6" title="Debt instrument face amount">156,250</span> to WOMF pursuant to a Securities Purchase Agreement between the Company and the WOMF (the “Stock Purchase Agreement”). The purchase price of the Note was $<span id="xdx_905_eus-gaap--DebtInstrumentRepurchaseAmount_iI_c20231027__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zOrKbwZlYRmj" title="Debt instrument repurchase amount">125,000</span>, representing a <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20231027__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zMqj3CKbUdn6" title="Original issue discount">20</span>% original issue discount. The Initial Note is non-interest bearing, except in the case of the event of a default, in which case interest will accrue from the date of the default at a rate equal to the lower of <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20231027__us-gaap--DebtInstrumentAxis__custom--InitialNoteMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_z9ukt3yFPl93" title="Debt instrument interest rate percentage">18</span>% per annum or the maximum rate permitted by law. The Initial Note becomes due on October 27, 2024. As of March 31, 2024, the total amounts outstanding were $<span id="xdx_90E_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240331__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z8VpjjPkKeB6" title="Debt carry amount">156,250</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WOMF may elect to convert the principal amount of the Initial Note and default interest, if any, subject to adjustment at a price equal to <span id="xdx_901_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_dp_c20231027__20231027__us-gaap--DebtInstrumentAxis__custom--InitialNoteMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ0Q8luzKesk" title="Lowest daily volume weighted average price">90</span>% of the lowest daily volume weighted average price of the common stock during the fifteen trading days preceding the conversion date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WOMF and/or investors introduced by WOMF may purchase up to an additional $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20231027__us-gaap--DebtInstrumentAxis__custom--NotesMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_zp83TGEUmqYb" title="Debt principal amount">1,693,750</span> aggregate principal amount of notes having terms substantially similar to the Initial Note (the “New Notes” and collectively with the Initial Note, the “Notes”). <span id="xdx_904_eus-gaap--DebtInstrumentDescription_c20231027__20231027__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zc9my9t0vj12" title="Debt instrument description">In addition to the principal and interest payment obligations under the Notes, the Company has agreed to pay and/or cause its newly formed 70% owned subsidiary, Nascent Pharma, LLC (“Nascent”,) to pay WOMF fifteen percent (15%) of all amounts that would otherwise be distributable to the Company by Nascent until WOMF receives distributions in the aggregate amount that equal the sum of (a) 200% of the purchase price of notes previously issued by the Company to WOMF plus (b) 200% of the principal amount of certain notes previously issued by the Company and acquired by WOMF from a third party plus (c) 100% of the purchase price of Notes purchased pursuant to the Stock Purchase Agreement; provided, however, if WOMF and/or other investors purchase $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20231027__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_z9bHeSYXK0mj" title="Debt principal amount">1,875,000</span> aggregate principal amount of Notes pursuant to the Stock Purchase Agreement, the obligation to pay 100% of the purchase price of the Notes shall be increased to 200% of the purchase price of such Notes.</span> The amounts distributable by Nascent to the Company, if any, will represent the proceeds of Nascent’s enforcement of certain patents it is seeking to acquire. Nascent has not yet acquired such patents and no assurance can be given that it will be able to complete such acquisition. Under the terms of the Stock Purchase Agreement, the purchase of New Notes by WOMF and/or investors introduced by WOMF is subject to, among other things, Nascent’s acquisition of the patents. If Nascent does not complete the acquisition of the patents, the Company does not expect that any New Notes will be purchased and the Company will have no obligation to pay additional consideration to WOMF.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event of a default under a Note, the Company shall be required to pay the holder of the Note an amount equal to the amount determined by multiplying the principal amount of the Note then outstanding plus default interest by <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231027__us-gaap--DebtInstrumentAxis__custom--InitialNoteMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zzdqyg0ds548" title="Debt instrument interest rate stated percentage">135</span>%, plus costs of collection. WOMF may elect to accept payment of any such amount in cash and/or shares of the Company’s common stock, valued for this purpose at the lower of the conversion price then in effect or a <span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20231027__20231027__us-gaap--DebtInstrumentAxis__custom--InitialNoteMember__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zWHnJ9RbK6Rk" title="Debt instrument convertible percentage">60</span>% discount to the lowest volume weighted average price of the common stock during the five trading days preceding the conversion date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WOMF has been granted a right of first refusal to participate in future financing transactions conducted by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into a Registration Rights Agreement with WOMF pursuant to which the Company has agreed to file a registration statement with the Securities and Exchange Commission by December 11, 2023 to register for public resale the shares of common stock issuable upon the conversion of the Note and a consolidated note issued to WOMF in the principal amount of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20231027_zgeQTnc4YJ3l" title="Principal amount">1,354,210</span> (the “Consolidated Note”) which combined certain notes held by WOMF into a single Note. If the Company fails to file the registration statement by December 11, 2023 or have the registration statement declared effective by the deadlines set forth in the Registration Rights Agreement, <span id="xdx_90B_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20231027__20231027__us-gaap--DebtInstrumentAxis__custom--ConsolidatedNoteMember_zRAAqqvItoc2" title="Debt instrument periodic payment">the Company will be required to make a payment of 2% of the amount then owed under the Note and the Consolidated Note for each 30 day period after the applicable deadline that the Company does not file the registration statement or the registration statement is not declared effective.</span> WOMF has also been granted piggyback registration rights with respect to the shares of common stock issuable upon the conversion of the Notes it acquires and the Consolidated Note. Each of the Initial Note and Consolidated Note grants full ratchet anti-dilution protection to WOMF in the event that the Company issues common stock or rights to purchase common stock at a price less than the conversion or exercise price then in effect.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Initial Note contains and the New Notes will contain a provision which provides that the holder will not be converted if the conversion would result in the holder becoming the beneficial owner of more than <span id="xdx_909_ecustom--PercentageOfOutstandingCommonStock_iI_pid_dp_uPure_c20231027_z5OskzT8PtMg" title="Percentage of outstanding common stock">9.99</span>% of the Company’s outstanding common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">ClearThink Notes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued a convertible note in the principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20230930__srt--TitleOfIndividualAxis__custom--HolderMember__dei--LegalEntityAxis__custom--WOMFMember_z3zWcSckwp83" title="Debt instrument face amount">15,000</span> to ClearThink Capital Partners, LLC (“ClearThink”) in September 2023 for a purchase price of $<span id="xdx_90F_ecustom--PurchaseAmountOfFutureReceivables_c20230930__20230930__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zosHv7S8eL5j" title="Debt instrument purchase amount">10,000</span>. The note has a six month term and is past due. A note in the principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20231231__srt--TitleOfIndividualAxis__custom--HolderMember__dei--LegalEntityAxis__custom--WOMFMember_zxqvup8YuGH2" title="Debt instrument face amount">75,000</span> was issued to ClearThink for a purchase price of $<span id="xdx_902_ecustom--PurchaseAmountOfFutureReceivables_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zmhdhYEstGB5" title="Debt instrument purchase amount">50,000</span> in December 2023. This note has a nine month term. Each of the notes bears interest at a rate of twelve percent (<span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zlXC9x0HiVmh" title="Debt instrument stated percentage">12</span>%) per annum and is convertible into the Company’s common stock at a conversion price of $<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zNPJzoAEvaN4" title="Debt instrument per share">.0772</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On February 29, 2024, the Company completed the sale of a promissory note in the principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20240229__srt--TitleOfIndividualAxis__custom--HolderMember__dei--LegalEntityAxis__custom--ClearThinkMember_zt3AW604ilZ3" title="Debt instrument principal amount">75,000</span> to ClearThink. The purchase price of the note was $<span id="xdx_90F_ecustom--PurchaseAmountOfFutureReceivables_c20240229__20240229__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_z3pRhV69IGKf" title="Debt instrument purchase amount">50,000</span>, representing a <span id="xdx_90E_ecustom--DebtInstrumentDiscountPercentage_iI_c20240229__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_ztB3a7vU92H3" title="Debt instrument discount percentage">33.33%</span> original issue discount. The note becomes due on November 29, 2024 and bears interest, payable upon maturity, at a rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240229__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zE28laVTZVI2" title="Debt instrument percentage">12</span>% per annum. ClearThink may convert the purchase price of the note and accrued and unpaid interest into shares of the Company’s common stock at any time at a conversion price of $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240229__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zSJQX4xUseM5" title="Debt instrument conversion price">0.0772</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other Loans</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company entered into various agreements relating to the sales of future receivables for an aggregate purchase amount of approximately $<span id="xdx_903_ecustom--PurchaseAmountOfFutureReceivables_c20220101__20221231_zUBtwYU5RDG9" title="Purchase amount of future receivables">450,000</span>. The aggregate principal amounts are payable in weekly installments ranging from $<span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zjSiLqpU1tX" title="Debt instrument periodic payment">2,917</span> through $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z4Y19ARARXU7" title="Debt instrument periodic payment">453</span> until such time the obligations are fully satisfied. As of March 31, 2024, the total amounts outstanding were approximately $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20240331_zm0fBHLrJwF9" title="Debt instrument, face amount">95,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 11, 2022, the Company entered into a $<span id="xdx_903_eus-gaap--UnsecuredDebt_iI_c20220211__us-gaap--RelatedPartyTransactionAxis__custom--LenderMember__us-gaap--TypeOfArrangementAxis__custom--UnsecuredPromissoryNoteAgreementMember__us-gaap--AwardTypeAxis__custom--DueWithinSixMonthsMember_z4OaQiy6GuGj" title="Unsecured promissory note">175,000</span> unsecured promissory note agreement with a lender. The promissory note accrues interest at a rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220211__us-gaap--RelatedPartyTransactionAxis__custom--LenderMember__us-gaap--TypeOfArrangementAxis__custom--UnsecuredPromissoryNoteAgreementMember__us-gaap--AwardTypeAxis__custom--DueWithinSixMonthsMember_zfhkaztc1SP3" title="Interest rate">16</span>% per annum and is due within six months or due on demand subsequently to any major funding received by the Company in excess of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_c20220209__20220211__us-gaap--RelatedPartyTransactionAxis__custom--LenderMember__us-gaap--TypeOfArrangementAxis__custom--UnsecuredPromissoryNoteAgreementMember__us-gaap--AwardTypeAxis__custom--DueWithinSixMonthsMember_zuI7bN8UaKae" title="Proceeds received from debt">2,000,000</span>. As of March 31, 2024the total amount outstanding was $<span id="xdx_90E_eus-gaap--ConvertibleDebt_iI_c20240331__us-gaap--RelatedPartyTransactionAxis__custom--LenderMember__us-gaap--TypeOfArrangementAxis__custom--UnsecuredPromissoryNoteAgreementMember__us-gaap--AwardTypeAxis__custom--DueWithinSixMonthsMember_zXJK4CM12LUk" title="Debt instrument, face amount">175,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 14, 2022, the Company entered into a $<span id="xdx_906_eus-gaap--UnsecuredDebt_iI_c20221014__us-gaap--RelatedPartyTransactionAxis__custom--LenderMember__us-gaap--TypeOfArrangementAxis__custom--UnsecuredPromissoryNoteAgreementMember__us-gaap--AwardTypeAxis__custom--DueOnOctoberThirtyOneTwoThousandTwentyTwoMember_zzGSlN0hy5Zi" title="Unsecured promissory note">115,000</span> unsecured promissory note agreement with a lender. The promissory note accrues interest at a rate of <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221014__us-gaap--RelatedPartyTransactionAxis__custom--LenderMember__us-gaap--TypeOfArrangementAxis__custom--UnsecuredPromissoryNoteAgreementMember__us-gaap--AwardTypeAxis__custom--DueOnOctoberThirtyOneTwoThousandTwentyTwoMember_z65Rn82WzYL7" title="Interest rate">18</span>% per annum and was due on October 31, 2022. As of March 31, 2024 the total amount outstanding was $<span id="xdx_90E_eus-gaap--ConvertibleDebt_iI_c20240331__us-gaap--RelatedPartyTransactionAxis__custom--LenderMember__us-gaap--TypeOfArrangementAxis__custom--UnsecuredPromissoryNoteAgreementMember__us-gaap--AwardTypeAxis__custom--DueOnOctoberThirtyOneTwoThousandTwentyTwoMember_zLjY5Kud3Je6" title="Debt instrument, face amount">65,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 17, 2022, the Company entered into a $<span id="xdx_90E_eus-gaap--UnsecuredDebt_iI_c20221117__us-gaap--RelatedPartyTransactionAxis__custom--LenderMember__us-gaap--TypeOfArrangementAxis__custom--UnsecuredPromissoryNoteAgreementMember__us-gaap--AwardTypeAxis__custom--DueOnDecemberSeventeenTwoThousandTwentyTwoMember_zVEt7OoiWI7d">200,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unsecured promissory note agreement with a lender. The promissory note accrues interest at a rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221117__us-gaap--RelatedPartyTransactionAxis__custom--LenderMember__us-gaap--TypeOfArrangementAxis__custom--UnsecuredPromissoryNoteAgreementMember__us-gaap--AwardTypeAxis__custom--DueOnDecemberSeventeenTwoThousandTwentyTwoMember_zYjbaEJVKLCd">18</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum and was due on December 17, 2022. As of March 31, 2024 the total amount outstanding was $<span id="xdx_90B_eus-gaap--ConvertibleDebt_iI_c20240331__us-gaap--RelatedPartyTransactionAxis__custom--LenderMember__us-gaap--TypeOfArrangementAxis__custom--UnsecuredPromissoryNoteAgreementMember__us-gaap--AwardTypeAxis__custom--DueOnDecemberSeventeenTwoThousandTwentyTwoMember_zhOMQDEyPQul">125,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with certain of the notes discussed above, the Company issued warrants to various lenders to purchase a total of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20230302__srt--TitleOfIndividualAxis__custom--VariousLendersMember_zW3wqFkEtCZh" title="Number of warrants purchase">198,248</span> shares of the Company’s common stock. These warrants have <span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_pid_do_c20230302__20230302__srt--TitleOfIndividualAxis__custom--VariousLendersMember_z0FnCKvTfaFi" title="Intrinsic value">no</span> intrinsic value and their fair value is insignificant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related Party Note</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has entered into a promissory note with Pat Ferro, a co-founder of the Company. As of March 31, 2024, the total amount outstanding was $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20240331__srt--TitleOfIndividualAxis__custom--PatFerroMember_zP84UJ3suRCk">366,243</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2675239 2022-01-31 0.12 228419 228419 6.75 2400997 102539 2022-01-31 0.12 8755 8755 6.75 87773 1193135 2022-01-31 0.12 101978 101978 6.75 1073250 306865 2022-01-31 0.12 26228 26228 6.75 276750 300000 The holders agreed to allow the Company to extend the notes for two additional 30-day periods for $100,000 per extension. The holders also waived certain defaults under the notes. The Company subsequently elected to extend the maturity date to May 31, 2022 for the promise to pay an additional $100,000. 52319 2022-12-31 5000000 0.08 52319 250000 2023-03-22 0.12 39062 39062 6.40 66667 0.50 0.33 102623 350000 2023-03-22 0.12 39062 39062 6.40 93333 0.50 0.33 256667 150000 2023-04-22 0.12 23437 23437 6.40 40000 0.50 0.33 110000 62500 2023-06-06 0.12 9766 9766 6.40 62500 385000 2023-08-30 0.12 71296 71296 5.40 385000 100000 2023-04-12 0.12 752000 130000 1007500 1823529 1550000 0.15 0.18 232500 227941 4559 0.10 1823529 0 4.00 0.0772 4.00 0.90 4.00 1.35 0.60 1307190 0.90 5.40 5.40 437500 350000 0.20 0.40 0.18 256893 3877000 5700000 5700000 1500000 10000 0.18 150000 50000 1500000 50000 150000 1250000 232500 435000 0.18 0.15 1250000 100000 0.06 1050000 156250 125000 0.20 0.18 156250 0.90 1693750 In addition to the principal and interest payment obligations under the Notes, the Company has agreed to pay and/or cause its newly formed 70% owned subsidiary, Nascent Pharma, LLC (“Nascent”,) to pay WOMF fifteen percent (15%) of all amounts that would otherwise be distributable to the Company by Nascent until WOMF receives distributions in the aggregate amount that equal the sum of (a) 200% of the purchase price of notes previously issued by the Company to WOMF plus (b) 200% of the principal amount of certain notes previously issued by the Company and acquired by WOMF from a third party plus (c) 100% of the purchase price of Notes purchased pursuant to the Stock Purchase Agreement; provided, however, if WOMF and/or other investors purchase $1,875,000 aggregate principal amount of Notes pursuant to the Stock Purchase Agreement, the obligation to pay 100% of the purchase price of the Notes shall be increased to 200% of the purchase price of such Notes. 1875000 1.35 0.60 1354210 the Company will be required to make a payment of 2% of the amount then owed under the Note and the Consolidated Note for each 30 day period after the applicable deadline that the Company does not file the registration statement or the registration statement is not declared effective. 0.0999 15000 10000 75000 50000 0.12 0.0772 75000 50000 0.3333 0.12 0.0772 450000 2917 453 95000 175000 0.16 2000000 175000 115000 0.18 65000 200000 0.18 125000 198248 0 366243 <p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zDFzQeurEFlc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9 – <span id="xdx_82C_zyQqb21iz7uj">Stockholders’ Equity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred Stock</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_903_eus-gaap--PreferredStockVotingRights_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z5P1s6UT0lqb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each share of Series A Preferred Stock is convertible into 218 shares of CANB common stock and is entitled to </span><span id="xdx_902_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_c20240331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zrvEsqpQ5m0k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,444 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">votes. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Preferred Shares shall rank senior to all shares of Common Stock of the Company with respect to liquidation preferences and shall rank <i>pari passu</i> to all current and future series of preferred stock, unless otherwise stated in the certificate of designation for such preferred stock. In the event of a Liquidation Event, whether voluntary or involuntary, each holder may elect (i) to receive, in preference to the holders of Common Stock, a one-time liquidation preference on a per-share amount equal to the per-share value of preferred shares on the issuance date, as recorded in the Company’s financial records, or (ii) to participate <i>pari passu</i> with the Common Stock on an as-converted basis. Subject to any adjustments, the Series A holders shall be entitled to receive such dividends paid and distributions made to the holders of shares of Common Stock on an as converted basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each share of Series C Preferred Stock has preference to payment of dividends, if and when declared by the Company, compared to shares of our common stock. Each Preferred Series C share is convertible into <span id="xdx_90E_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_c20240331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zkhxCu4viMk5" title="Number of convertible shares">1,667</span> shares of common stock. The shares of Series C Preferred Stock have voting rights as if fully converted. During the year ended December 31, 2022 the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zEmkblPylUn9" title="Stock issued during the period">1,077</span> shares of Series C preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PreferredStockVotingRights_c20240101__20240331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zgVxiHZFQj57" title="Preferred stock, voting rights">Each share of Series D Preferred Stock has 667 shares of voting rights only pari passu to common shares voting with no conversion rights and no equity participation. The Company can redeem Series D Preferred Stock at any time for par value.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 8, 2021, the Company’s Board of Directors approved the designation of the Series D Preferred Shares and the number of shares constituting such series, and the rights, powers, preferences, privileges and restrictions relating to such series. On March 27, 2021, the Company filed an amendment to its articles of incorporation to authorize <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20210327__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zLPgbbt38EGf" title="Preferred stock shares authorized">4,000</span> shares of a new Series D Preferred Stock with a par value of $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210327__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_z1jhefBTQiv6" title="Preferred stock, par value">0.001</span> each. All Series D Preferred Shares shall rank senior to all shares of Common Stock of the Company with respect to liquidation preferences and shall rank <i>pari passu</i> to all current and future series of preferred stock, unless otherwise stated in the certificate of designation for such preferred stock. <span id="xdx_902_eus-gaap--PreferredStockVotingRights_c20210207__20210208__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zBIaphBQakrd" title="Preferred stock, voting rights">Each Series D Preferred Share shall have voting rights equal to 667 shares of Common Stock, adjustable at any recapitalization of the Company’s stock. In the event of a liquidation event, whether voluntary or involuntary, each holder shall have a liquidation preference on a per-share amount equal to the par value of such holder’s Series D Preferred Shares. The holders shall not be entitled to receive distributions made or dividends paid to the Company’s other stockholders. Except as otherwise required by law, for as long as any Series D Preferred Shares remain outstanding, the Company shall have the option to redeem any outstanding share of Series D Preferred Shares at any time for a purchase price of par value per share of Series D Preferred Shares (“Price per Share”).</span> Should the Company desire to purchase Series D Preferred Shares, the Company shall provide the Holder with written notice and a check or cash in an amount equal to the number of shares of Series D Preferred Shares being purchased multiplied by the Price per Share. The shares of Series D Preferred Shares so purchased shall be deemed automatically cancelled and the Holder shall return the certificates for such share to the Corporation. During the year ended December 31, 2022 the Company issued <span id="xdx_908_ecustom--StockIssuedDuringPeriodSharesPreferredStock_c20220101__20221231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zYfSvwmn9eoe" title="Stock issued during the period">2,050</span> shares of Series D preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Can B̅ Corp. and Subsidiaries</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Condensed Notes to Unaudited Consolidated Financial Statements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, 2024</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> Each share of Series A Preferred Stock is convertible into 218 shares of CANB common stock and is entitled to 4444 1667 1077 Each share of Series D Preferred Stock has 667 shares of voting rights only pari passu to common shares voting with no conversion rights and no equity participation. The Company can redeem Series D Preferred Stock at any time for par value. 4000 0.001 Each Series D Preferred Share shall have voting rights equal to 667 shares of Common Stock, adjustable at any recapitalization of the Company’s stock. In the event of a liquidation event, whether voluntary or involuntary, each holder shall have a liquidation preference on a per-share amount equal to the par value of such holder’s Series D Preferred Shares. The holders shall not be entitled to receive distributions made or dividends paid to the Company’s other stockholders. Except as otherwise required by law, for as long as any Series D Preferred Shares remain outstanding, the Company shall have the option to redeem any outstanding share of Series D Preferred Shares at any time for a purchase price of par value per share of Series D Preferred Shares (“Price per Share”). 2050 <p id="xdx_80A_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z86hD09o5b0h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10 – <span id="xdx_827_zYMCLCa9fSGi">Stock Options</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The fair value of each option award is estimated on the date of grant using a Black Scholes option valuation model that uses the assumptions noted in the following table. Because Black Scholes option valuation models incorporate ranges of assumptions for inputs, those ranges are disclosed. Expected volatilities are based on implied volatilities from traded options on the Company’s stock, historical volatility of the Company’s stock, and other factors. The expected term of options granted is derived from the output of the option valuation model and represents the period of time that options granted are expected to be outstanding; the range given below results from certain groups of employees exhibiting different behavior. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.</p> <p id="xdx_89C_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z0zYRrEcxd9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zP6W8PB26Aoe" style="display: none">Schedule of Stock Option Valuation Assumptions</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>March 31,</b></span></p> <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span><b>March 31,</b></span></p> <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Per share fair value at grant date</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20240331__srt--RangeAxis__srt--MinimumMember_zqvIrOl6X2a5" title="Per share fair value at grant date">0.036</span>-<span id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20240331__srt--RangeAxis__srt--MaximumMember_zxOxW3OMl5Sd" title="Per share fair value at grant date">0.05</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">    <span id="xdx_907_eus-gaap--SharePrice_iI_pid_c20230331_zt4W0BeRzKg9" title="Per share fair value at grant date"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20240331_zYKon3LU9Sx5" title="Risk free interest rate, Minimum">4.12</span>%-<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240331_zv43I2Z9NqQ" title="Risk free interest rate, maximum">4.30</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Expected volatility</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240331_zqma3jvAJHL3" title="Expected volatility">224</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20240331_zovRgBZS8io4" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240331_z8yPA6yUMkEk" title="Expected life in years">5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A4_zLvnaEzYDrbe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z6QnaigbMuJl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of stock options activity for the three months ended March 31, 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zdnyywsBXijk" style="display: none">Schedule of Stock Options Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Contractual Life (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Outstanding, January 1, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240331_zvZBaTsnVznj" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Option shares, outstanding beginning">12,223,331</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240331_zf87u0mdXwH6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted average exercise price, outstanding beginning">3.08</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zdGBC5Gexhe6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted average remaining contractual life years, outstanding beginning">3.89</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331_ziHwJVvkRmmf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Option shares, granted">27,019,284</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240331_z8c8xjKCSJhj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, granted">0.04</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331_zKxpKdpxYVk3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life years, granted">5.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240331_zFpscF4nsIJ2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock based compensation, shares"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240101__20240331_zxgXAYCVkR5e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercised"><span style="-sec-ix-hidden: xdx2ixbrl1176">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20240101__20240331_zsIF7H1yCmwf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Option shares, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240331_zKMOm6aWETje" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20240101__20240331_zMq0kWgus7C2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Option shares, expired"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20240331_zRMzmmM15zJd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, expired"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Outstanding, March 31, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240331_zdENTkvJKygc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Option shares, outstanding ending">39,242,615</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240331_zFDl4taf1O58" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending">0.99</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331_zdA8hTYwTZLa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life years, outstanding ending">3.92</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zIiM84jlYMCg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation expense related to stock options during the three months ended March 31, 2024 was $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20240101__20240331_zdOAXQaLy2Ei" title="Share based compensation expense">1,163,636</span>. <span id="xdx_90F_eus-gaap--ShareBasedCompensation_dxL_c20230101__20230331_zz4oRh5ePkai" title="Share based compensation expense::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1194">No</span></span> stock-based compensation was recognized for the three months ended March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_z0zYRrEcxd9f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zP6W8PB26Aoe" style="display: none">Schedule of Stock Option Valuation Assumptions</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"><b>March 31,</b></span></p> <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0; margin-bottom: 0"><span><b>March 31,</b></span></p> <p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Per share fair value at grant date</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20240331__srt--RangeAxis__srt--MinimumMember_zqvIrOl6X2a5" title="Per share fair value at grant date">0.036</span>-<span id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20240331__srt--RangeAxis__srt--MaximumMember_zxOxW3OMl5Sd" title="Per share fair value at grant date">0.05</span></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">    <span id="xdx_907_eus-gaap--SharePrice_iI_pid_c20230331_zt4W0BeRzKg9" title="Per share fair value at grant date"><span style="-sec-ix-hidden: xdx2ixbrl1148">-</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20240331_zYKon3LU9Sx5" title="Risk free interest rate, Minimum">4.12</span>%-<span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240331_zv43I2Z9NqQ" title="Risk free interest rate, maximum">4.30</span></span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: left">Expected volatility</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240101__20240331_zqma3jvAJHL3" title="Expected volatility">224</span></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240101__20240331_zovRgBZS8io4" title="Dividend yield">0</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240331_z8yPA6yUMkEk" title="Expected life in years">5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table> 0.036 0.05 0.0412 0.0430 2.24 0 P5Y <p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z6QnaigbMuJl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of stock options activity for the three months ended March 31, 2024 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zdnyywsBXijk" style="display: none">Schedule of Stock Options Activity</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Contractual Life (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Outstanding, January 1, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240331_zvZBaTsnVznj" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Option shares, outstanding beginning">12,223,331</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20240101__20240331_zf87u0mdXwH6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted average exercise price, outstanding beginning">3.08</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zdGBC5Gexhe6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted average remaining contractual life years, outstanding beginning">3.89</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240331_ziHwJVvkRmmf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Option shares, granted">27,019,284</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20240101__20240331_z8c8xjKCSJhj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, granted">0.04</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331_zKxpKdpxYVk3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life years, granted">5.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240331_zFpscF4nsIJ2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Stock based compensation, shares"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20240101__20240331_zxgXAYCVkR5e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercised"><span style="-sec-ix-hidden: xdx2ixbrl1176">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20240101__20240331_zsIF7H1yCmwf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Option shares, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1178">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20240101__20240331_zKMOm6aWETje" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20240101__20240331_zMq0kWgus7C2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Option shares, expired"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20240101__20240331_zRMzmmM15zJd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, expired"><span style="-sec-ix-hidden: xdx2ixbrl1184">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Outstanding, March 31, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240331_zdENTkvJKygc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Option shares, outstanding ending">39,242,615</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20240101__20240331_zFDl4taf1O58" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending">0.99</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240331_zdA8hTYwTZLa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life years, outstanding ending">3.92</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12223331 3.08 P3Y10M20D 27019284 0.04 P5Y 39242615 0.99 P3Y11M1D 1163636 <p id="xdx_805_eus-gaap--IncomeTaxDisclosureTextBlock_zqxRxnKkrCdk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11 – <span id="xdx_820_z4eyCpcnNdLh">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s income tax provisions for the three months ended March 31, 2024 and 2023 reflect the Company’s estimates of the effective rates expected to be applicable for the respective full years, adjusted for any discrete events, which are recorded in the period that they occur. These estimates are reevaluated each quarter based on the Company’s estimated tax expense for the full year. The estimated effective tax rate includes the impact of valuation allowances in various jurisdictions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zeqWcuMrIOP4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12 – <span id="xdx_82B_zIX8dplIGVBh">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lease Agreements</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company leases office space in numerous medical facilities offices under month-to-month agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z2DrSqoi4r05" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2024, the future minimum lease payments under non-cancellable operating leases were:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8BE_zYaWAgUXK9R7" style="display: none">Schedule of Future Maturities of Lease Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_493_20240331_zZOyPsIzXm52" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_zizbDxMT5czk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 84%">Nine months ended December 31, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">294,818</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zUNbRot4n7la" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Fiscal year 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1204">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zvqti0X5gdxc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">294,818</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zJjLTolcOkV4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_z2DrSqoi4r05" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2024, the future minimum lease payments under non-cancellable operating leases were:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_8BE_zYaWAgUXK9R7" style="display: none">Schedule of Future Maturities of Lease Liabilities</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_493_20240331_zZOyPsIzXm52" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_zizbDxMT5czk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 84%">Nine months ended December 31, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">294,818</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zUNbRot4n7la" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Fiscal year 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1204">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_zvqti0X5gdxc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total future minimum lease payments</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">294,818</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 294818 294818 <p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zcthTnc1atuj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 13 – <span id="xdx_82C_zuiLS6rDkW1h">Subsequent Events</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the condensed consolidated financial statements are issued and as of that date. There were no subsequent events that required adjustment or disclosure in the condensed consolidated financial statements, except as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In April 2024 the Company and the landlord of its Hicksville, New York office settled an action instituted by the landlord seeking unpaid rent and possession of the premises pursuant to an agreement which required the Company to move to a smaller space in the same facility at a reduced rent and requires the Company to pay back rent over a period of time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On April 7, 2024, Arena filed a complaint in the Supreme Court, County of New York against the Company, it subsidiaries and certain officers of the Company and its subsidiaries alleging tortious interference with the auction conducted under Article 9 of the Uniform Commercial Code in March 2014 and seeking a declaratory judgment that the Company is in breach of the Arena notes and the Forbearance Agreement and that Arena has the right to auction certain equipment held at a Company facility that is not owned by the Company or any of its subsidiaries. The Company believes that Arena’s claims are without merit and intends to vigorously defend Arena’s claims.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In June 2024, the Company’s Board of Directors concluded that as a result of the impact of the auction conducted by Arena under Article 9 of the Uniform Commercial Code on the hemp division, it was no longer feasible to continue the Company’s hemp operations. As a result, the Company is no longer pursuing the development, manufacture or sale of hemp derived products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company was a party to a Hemp Purchase Agreement with One Bad Moon Rising, LLC (“OBMR”). OMBR alleged that the Company breached the agreement and advised the Company that it would seek to enforce its rights under the contract if OBMR’s proposal to settle the matter was not accepted. The matter was settled in June 2024 pursuant to an agreement which required the Company to return approximately <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesOther_c20240601__20240630__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zZi6aowX8x99" title="Number of shares of stock issued, shares">1,800,000</span> pounds of hemp biomass to OBMR and issue OBMR <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240601__20240630__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_z8DWxfNRJsfe" title="Number of shares issued, shares">4,825,000</span> shares of its common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 14, 2024, an auction of the assets of our hemp division was conducted under Article 9 of the Uniform Commercial Code following allegations by Arena that we were in breach of our obligations under certain notes and a forbearance agreement. See “Part II Item 1. Legal Proceedings.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the auction, we continued our hemp operations on a reduced scale using equipment provided by third parties and the services of third-party processors. Historically, revenues from our hemp division supported, in part, our durable medical equipment business conducted through Duramed. Due to reduced support from the hemp division, Duramed is operating with reduced staff which has adversely impacted revenues. Subsequent to March 31, 2024, our Board of Directors concluded that as a result of the impact of the auction conducted by Arena under Article 9 of the Uniform Commercial Code on the hemp division, it is no longer feasible to continue our hemp operations. As a result, we are no longer pursuing the development, manufacture or sale of hemp derived products. Going forward, our primary focus will be on protecting and commercializing the cannabis patents acquired by Nascent, continuing to collect Duramed receivables and reestablishing the Company’s production of the Longevity Brand Superfood drink mix for Brooke Burke Body, Inc</span></p> 1800000 4825000